id	sid	tid	token	lemma	pos
admet-207	1	1	manuscript	manuscript	PROPN
admet-207	1	2	doi	doi	PROPN
admet-207	1	3	:	:	PUNCT
admet-207	1	4	10.5599	10.5599	NUM
admet-207	1	5	/	/	SYM
admet-207	1	6	admet.0000.0000	admet.0000.0000	PROPN
admet-207	1	7	254	254	NUM
admet-207	1	8	admet	admet	X
admet-207	1	9	&	&	CCONJ
admet-207	1	10	dmpk	dmpk	PROPN
admet-207	1	11	3(3	3(3	NUM
admet-207	1	12	)	)	PUNCT
admet-207	1	13	(	(	PUNCT
admet-207	1	14	2015	2015	NUM
admet-207	1	15	)	)	PUNCT
admet-207	1	16	254	254	NUM
admet-207	1	17	-	-	SYM
admet-207	1	18	259	259	NUM
admet-207	1	19	;	;	PUNCT
admet-207	1	20	doi	doi	NOUN
admet-207	1	21	:	:	PUNCT
admet-207	1	22	10.5599	10.5599	NUM
admet-207	1	23	/	/	SYM
admet-207	1	24	admet.3.3.207	admet.3.3.207	NOUN
admet-207	1	25	open	open	VERB
admet-207	1	26	access	access	NOUN
admet-207	1	27	:	:	PUNCT
admet-207	1	28	issn	issn	PROPN
admet-207	1	29	:	:	PUNCT
admet-207	1	30	1848	1848	NUM
admet-207	1	31	-	-	SYM
admet-207	1	32	7718	7718	NUM
admet-207	1	33	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-207	1	34	review	review	VERB
admet-207	1	35	an	an	DET
admet-207	1	36	overview	overview	NOUN
admet-207	1	37	on	on	ADP
admet-207	1	38	the	the	DET
admet-207	1	39	role	role	NOUN
admet-207	1	40	of	of	ADP
admet-207	1	41	telomere	telomere	NOUN
admet-207	1	42	,	,	PUNCT
admet-207	1	43	telomerase	telomerase	NOUN
admet-207	1	44	in	in	ADP
admet-207	1	45	degenerative	degenerative	ADJ
admet-207	1	46	diseases	disease	NOUN
admet-207	1	47	and	and	CCONJ
admet-207	1	48	cancer	cancer	NOUN
admet-207	1	49	churong	churong	NOUN
admet-207	1	50	li1	li1	NOUN
admet-207	1	51	,	,	PUNCT
admet-207	1	52	yin	yin	PROPN
admet-207	1	53	gang1	gang1	PROPN
admet-207	1	54	*	*	SYM
admet-207	1	55	1	1	NUM
admet-207	1	56	department	department	NOUN
admet-207	1	57	of	of	ADP
admet-207	1	58	radiotherapy	radiotherapy	NOUN
admet-207	1	59	,	,	PUNCT
admet-207	1	60	si	si	PROPN
admet-207	1	61	chuan	chuan	PROPN
admet-207	1	62	cancer	cancer	PROPN
admet-207	1	63	hospital	hospital	PROPN
admet-207	1	64	,	,	PUNCT
admet-207	1	65	chengdu	chengdu	PROPN
admet-207	1	66	,	,	PUNCT
admet-207	1	67	sichuan	sichuan	PROPN
admet-207	1	68	province	province	PROPN
admet-207	1	69	,	,	PUNCT
admet-207	1	70	china	china	PROPN
admet-207	1	71	*	*	PUNCT
admet-207	1	72	corresponding	correspond	VERB
admet-207	1	73	author	author	NOUN
admet-207	1	74	:	:	PUNCT
admet-207	1	75	e	e	NOUN
admet-207	1	76	-	-	NOUN
admet-207	1	77	mail	mail	NOUN
admet-207	1	78	:	:	PUNCT
admet-207	2	1	cxqyguestc@163.com	cxqyguestc@163.com	ADJ
admet-207	2	2	;	;	PUNCT
admet-207	2	3	tel	tel	PROPN
admet-207	2	4	.	.	PUNCT
admet-207	2	5	:	:	PUNCT
admet-207	3	1	+86	+86	PROPN
admet-207	3	2	028	028	NUM
admet-207	3	3	-	-	PUNCT
admet-207	3	4	85420305	85420305	NUM
admet-207	3	5	;	;	PUNCT
admet-207	3	6	fax	fax	NOUN
admet-207	3	7	:	:	PUNCT
admet-207	3	8	+86	+86	PROPN
admet-207	3	9	028	028	NUM
admet-207	3	10	-	-	SYM
admet-207	3	11	85420305	85420305	NUM
admet-207	3	12	received	receive	VERB
admet-207	3	13	:	:	PUNCT
admet-207	3	14	august	august	PROPN
admet-207	3	15	07	07	NUM
admet-207	3	16	,	,	PUNCT
admet-207	3	17	2015	2015	NUM
admet-207	3	18	;	;	PUNCT
admet-207	3	19	revised	revise	VERB
admet-207	3	20	:	:	PUNCT
admet-207	3	21	august	august	PROPN
admet-207	3	22	20	20	NUM
admet-207	3	23	,	,	PUNCT
admet-207	3	24	2015	2015	NUM
admet-207	3	25	;	;	PUNCT
admet-207	3	26	published	publish	VERB
admet-207	3	27	:	:	PUNCT
admet-207	3	28	september	september	PROPN
admet-207	3	29	05	05	NUM
admet-207	3	30	,	,	PUNCT
admet-207	3	31	2015	2015	NUM
admet-207	3	32	abstract	abstract	ADJ
admet-207	3	33	telomerase	telomerase	NOUN
admet-207	3	34	maintains	maintain	VERB
admet-207	3	35	the	the	DET
admet-207	3	36	length	length	NOUN
admet-207	3	37	of	of	ADP
admet-207	3	38	telomeric	telomeric	ADJ
admet-207	3	39	dna	dna	NOUN
admet-207	3	40	at	at	ADP
admet-207	3	41	the	the	DET
admet-207	3	42	end	end	NOUN
admet-207	3	43	of	of	ADP
admet-207	3	44	chromosomes	chromosome	NOUN
admet-207	3	45	;	;	PUNCT
admet-207	3	46	stabilizes	stabilize	VERB
admet-207	3	47	the	the	DET
admet-207	3	48	functions	function	NOUN
admet-207	3	49	of	of	ADP
admet-207	3	50	chromosomes	chromosome	NOUN
admet-207	3	51	,	,	PUNCT
admet-207	3	52	protects	protect	VERB
admet-207	3	53	the	the	DET
admet-207	3	54	structure	structure	NOUN
admet-207	3	55	of	of	ADP
admet-207	3	56	chromosome	chromosome	NOUN
admet-207	3	57	dna	dna	NOUN
admet-207	3	58	and	and	CCONJ
admet-207	3	59	regulates	regulate	VERB
admet-207	3	60	normal	normal	ADJ
admet-207	3	61	cell	cell	NOUN
admet-207	3	62	growth	growth	NOUN
admet-207	3	63	.	.	PUNCT
admet-207	4	1	the	the	DET
admet-207	4	2	length	length	NOUN
admet-207	4	3	and	and	CCONJ
admet-207	4	4	stability	stability	NOUN
admet-207	4	5	of	of	ADP
admet-207	4	6	telomeres	telomere	NOUN
admet-207	4	7	determine	determine	VERB
admet-207	4	8	the	the	DET
admet-207	4	9	cellular	cellular	ADJ
admet-207	4	10	lifespan	lifespan	NOUN
admet-207	4	11	.	.	PUNCT
admet-207	5	1	moreover	moreover	ADV
admet-207	5	2	,	,	PUNCT
admet-207	5	3	they	they	PRON
admet-207	5	4	correlate	correlate	VERB
admet-207	5	5	with	with	ADP
admet-207	5	6	cellular	cellular	ADJ
admet-207	5	7	aging	aging	NOUN
admet-207	5	8	and	and	CCONJ
admet-207	5	9	carcinogenesis	carcinogenesis	NOUN
admet-207	5	10	.	.	PUNCT
admet-207	6	1	researches	research	VERB
admet-207	6	2	on	on	ADP
admet-207	6	3	the	the	DET
admet-207	6	4	role	role	NOUN
admet-207	6	5	of	of	ADP
admet-207	6	6	telomerase	telomerase	NOUN
admet-207	6	7	in	in	ADP
admet-207	6	8	degenerative	degenerative	ADJ
admet-207	6	9	diseases	disease	NOUN
admet-207	6	10	and	and	CCONJ
admet-207	6	11	cancers	cancer	NOUN
admet-207	6	12	show	show	VERB
admet-207	6	13	that	that	SCONJ
admet-207	6	14	it	it	PRON
admet-207	6	15	regulates	regulate	VERB
admet-207	6	16	cellular	cellular	ADJ
admet-207	6	17	senescence	senescence	NOUN
admet-207	6	18	.	.	PUNCT
admet-207	7	1	although	although	SCONJ
admet-207	7	2	telomerase	telomerase	NOUN
admet-207	7	3	is	be	AUX
admet-207	7	4	not	not	PART
admet-207	7	5	an	an	DET
admet-207	7	6	oncogene	oncogene	NOUN
admet-207	7	7	,	,	PUNCT
admet-207	7	8	it	it	PRON
admet-207	7	9	does	do	AUX
admet-207	7	10	make	make	VERB
admet-207	7	11	tumor	tumor	NOUN
admet-207	7	12	cells	cell	NOUN
admet-207	7	13	immortal	immortal	ADJ
admet-207	7	14	by	by	ADP
admet-207	7	15	maintaining	maintain	VERB
admet-207	7	16	the	the	DET
admet-207	7	17	stability	stability	NOUN
admet-207	7	18	of	of	ADP
admet-207	7	19	telomeric	telomeric	ADJ
admet-207	7	20	dna	dna	PROPN
admet-207	7	21	.	.	PUNCT
admet-207	8	1	telomerase	telomerase	NOUN
admet-207	8	2	-	-	PUNCT
admet-207	8	3	based	base	VERB
admet-207	8	4	therapies	therapy	NOUN
admet-207	8	5	have	have	AUX
admet-207	8	6	become	become	VERB
admet-207	8	7	a	a	DET
admet-207	8	8	hotspot	hotspot	NOUN
admet-207	8	9	in	in	ADP
admet-207	8	10	new	new	ADJ
admet-207	8	11	anticancer	anticancer	NOUN
admet-207	8	12	and	and	CCONJ
admet-207	8	13	degenerative	degenerative	ADJ
admet-207	8	14	diseases	disease	NOUN
admet-207	8	15	treatments	treatment	NOUN
admet-207	8	16	.	.	PUNCT
admet-207	9	1	this	this	DET
admet-207	9	2	review	review	NOUN
admet-207	9	3	aims	aim	VERB
admet-207	9	4	to	to	PART
admet-207	9	5	provide	provide	VERB
admet-207	9	6	a	a	DET
admet-207	9	7	comprehensive	comprehensive	ADJ
admet-207	9	8	understanding	understanding	NOUN
admet-207	9	9	of	of	ADP
admet-207	9	10	the	the	DET
admet-207	9	11	role	role	NOUN
admet-207	9	12	of	of	ADP
admet-207	9	13	telomerase	telomerase	NOUN
admet-207	9	14	and	and	CCONJ
admet-207	9	15	telomere	telomere	NOUN
admet-207	9	16	in	in	ADP
admet-207	9	17	cellular	cellular	ADJ
admet-207	9	18	senescence	senescence	NOUN
admet-207	9	19	and	and	CCONJ
admet-207	9	20	cancer	cancer	NOUN
admet-207	9	21	.	.	PUNCT
admet-207	10	1	keywords	keyword	NOUN
admet-207	10	2	telomerase	telomerase	VERB
admet-207	10	3	;	;	PUNCT
admet-207	10	4	telomere	telomere	NOUN
admet-207	10	5	;	;	PUNCT
admet-207	10	6	degeneration	degeneration	NOUN
admet-207	10	7	diseases	disease	NOUN
admet-207	10	8	;	;	PUNCT
admet-207	10	9	cancer	cancer	NOUN
admet-207	10	10	introduction	introduction	NOUN
admet-207	10	11	telomeres	telomere	NOUN
admet-207	10	12	are	be	AUX
admet-207	10	13	specialized	specialized	ADJ
admet-207	10	14	structures	structure	NOUN
admet-207	10	15	located	locate	VERB
admet-207	10	16	at	at	ADP
admet-207	10	17	the	the	DET
admet-207	10	18	terminal	terminal	ADJ
admet-207	10	19	ends	end	NOUN
admet-207	10	20	of	of	ADP
admet-207	10	21	chromosomes	chromosome	NOUN
admet-207	10	22	and	and	CCONJ
admet-207	10	23	play	play	VERB
admet-207	10	24	a	a	DET
admet-207	10	25	critical	critical	ADJ
admet-207	10	26	role	role	NOUN
admet-207	10	27	in	in	ADP
admet-207	10	28	stabilization	stabilization	NOUN
admet-207	10	29	of	of	ADP
admet-207	10	30	chromosomes	chromosome	NOUN
admet-207	10	31	,	,	PUNCT
admet-207	10	32	maintaining	maintain	VERB
admet-207	10	33	the	the	DET
admet-207	10	34	integrity	integrity	NOUN
admet-207	10	35	of	of	ADP
admet-207	10	36	the	the	DET
admet-207	10	37	genome	genome	NOUN
admet-207	11	1	[	[	X
admet-207	11	2	1,2	1,2	NUM
admet-207	11	3	]	]	PUNCT
admet-207	11	4	,	,	PUNCT
admet-207	11	5	and	and	CCONJ
admet-207	11	6	regulation	regulation	NOUN
admet-207	11	7	of	of	ADP
admet-207	11	8	normal	normal	ADJ
admet-207	11	9	cell	cell	NOUN
admet-207	11	10	growth	growth	NOUN
admet-207	11	11	.	.	PUNCT
admet-207	12	1	telomerase	telomerase	NOUN
admet-207	12	2	is	be	AUX
admet-207	12	3	a	a	DET
admet-207	12	4	reverse	reverse	ADJ
admet-207	12	5	transcriptase	transcriptase	NOUN
admet-207	12	6	enzyme	enzyme	NOUN
admet-207	12	7	which	which	PRON
admet-207	12	8	synthesizes	synthesize	VERB
admet-207	12	9	the	the	DET
admet-207	12	10	g	g	NOUN
admet-207	12	11	-	-	PUNCT
admet-207	12	12	rich	rich	ADJ
admet-207	12	13	tandem	tandem	NOUN
admet-207	12	14	repeats	repeat	NOUN
admet-207	12	15	that	that	PRON
admet-207	12	16	comprise	comprise	VERB
admet-207	12	17	telomeres	telomere	NOUN
admet-207	12	18	using	use	VERB
admet-207	12	19	a	a	DET
admet-207	12	20	template	template	NOUN
admet-207	12	21	on	on	ADP
admet-207	12	22	the	the	DET
admet-207	12	23	rna	rna	NOUN
admet-207	12	24	that	that	PRON
admet-207	12	25	is	be	AUX
admet-207	12	26	complementary	complementary	ADJ
admet-207	12	27	to	to	ADP
admet-207	12	28	the	the	DET
admet-207	12	29	telomeric	telomeric	ADJ
admet-207	12	30	repeat	repeat	NOUN
admet-207	12	31	.	.	PUNCT
admet-207	13	1	by	by	ADP
admet-207	13	2	adding	add	VERB
admet-207	13	3	hexameric	hexameric	NOUN
admet-207	13	4	(	(	PUNCT
admet-207	13	5	ttaggg	ttaggg	NOUN
admet-207	13	6	)	)	PUNCT
admet-207	13	7	repeats	repeat	NOUN
admet-207	13	8	,	,	PUNCT
admet-207	13	9	the	the	DET
admet-207	13	10	continued	continue	VERB
admet-207	13	11	erosion	erosion	NOUN
admet-207	13	12	of	of	ADP
admet-207	13	13	telomeres	telomere	NOUN
admet-207	13	14	is	be	AUX
admet-207	13	15	compensated	compensate	VERB
admet-207	13	16	.	.	PUNCT
admet-207	14	1	over	over	ADP
admet-207	14	2	the	the	DET
admet-207	14	3	past	past	ADJ
admet-207	14	4	few	few	ADJ
admet-207	14	5	decades	decade	NOUN
admet-207	14	6	,	,	PUNCT
admet-207	14	7	studies	study	NOUN
admet-207	14	8	have	have	AUX
admet-207	14	9	shown	show	VERB
admet-207	14	10	that	that	SCONJ
admet-207	14	11	telomeres	telomere	NOUN
admet-207	14	12	and	and	CCONJ
admet-207	14	13	telomerase	telomerase	NOUN
admet-207	14	14	are	be	AUX
admet-207	14	15	closely	closely	ADV
admet-207	14	16	related	relate	VERB
admet-207	14	17	to	to	ADP
admet-207	14	18	cellular	cellular	ADJ
admet-207	14	19	malfunction	malfunction	NOUN
admet-207	14	20	,	,	PUNCT
admet-207	14	21	degenerative	degenerative	ADJ
admet-207	14	22	diseases	disease	NOUN
admet-207	14	23	and	and	CCONJ
admet-207	14	24	tumor	tumor	NOUN
admet-207	14	25	progression	progression	NOUN
admet-207	14	26	.	.	PUNCT
admet-207	15	1	therefore	therefore	ADV
admet-207	15	2	,	,	PUNCT
admet-207	15	3	researches	research	VERB
admet-207	15	4	into	into	ADP
admet-207	15	5	the	the	DET
admet-207	15	6	role	role	NOUN
admet-207	15	7	of	of	ADP
admet-207	15	8	telomerase	telomerase	NOUN
admet-207	15	9	and	and	CCONJ
admet-207	15	10	telomere	telomere	NOUN
admet-207	15	11	in	in	ADP
admet-207	15	12	degenerative	degenerative	ADJ
admet-207	15	13	diseases	disease	NOUN
admet-207	15	14	and	and	CCONJ
admet-207	15	15	cancer	cancer	NOUN
admet-207	15	16	shed	shed	VERB
admet-207	15	17	light	light	NOUN
admet-207	15	18	on	on	ADP
admet-207	15	19	a	a	DET
admet-207	15	20	better	well	ADJ
admet-207	15	21	understanding	understanding	NOUN
admet-207	15	22	of	of	ADP
admet-207	15	23	these	these	DET
admet-207	15	24	diseases	disease	NOUN
admet-207	15	25	.	.	PUNCT
admet-207	16	1	telomerase	telomerase	NOUN
admet-207	16	2	-	-	PUNCT
admet-207	16	3	based	base	VERB
admet-207	16	4	therapies	therapy	NOUN
admet-207	16	5	,	,	PUNCT
admet-207	16	6	including	include	VERB
admet-207	16	7	targeted	target	VERB
admet-207	16	8	agents	agent	NOUN
admet-207	16	9	will	will	AUX
admet-207	16	10	open	open	VERB
admet-207	16	11	up	up	ADP
admet-207	16	12	a	a	DET
admet-207	16	13	whole	whole	ADJ
admet-207	16	14	new	new	ADJ
admet-207	16	15	horizon	horizon	NOUN
admet-207	16	16	for	for	ADP
admet-207	16	17	degenerative	degenerative	ADJ
admet-207	16	18	diseases	disease	NOUN
admet-207	16	19	and	and	CCONJ
admet-207	16	20	cancer	cancer	NOUN
admet-207	16	21	treatments	treatment	NOUN
admet-207	16	22	.	.	PUNCT
admet-207	17	1	telomeres	telomere	NOUN
admet-207	17	2	,	,	PUNCT
admet-207	17	3	telomerase	telomerase	NOUN
admet-207	17	4	and	and	CCONJ
admet-207	17	5	their	their	PRON
admet-207	17	6	relationship	relationship	NOUN
admet-207	17	7	telomere	telomere	ADV
admet-207	17	8	,	,	PUNCT
admet-207	17	9	from	from	ADP
admet-207	17	10	the	the	DET
admet-207	17	11	greek	greek	ADJ
admet-207	17	12	word	word	NOUN
admet-207	17	13	“	"	PUNCT
admet-207	17	14	telos	telos	X
admet-207	17	15	,	,	PUNCT
admet-207	17	16	”	"	PUNCT
admet-207	17	17	(	(	PUNCT
admet-207	17	18	end	end	NOUN
admet-207	17	19	)	)	PUNCT
admet-207	17	20	,	,	PUNCT
admet-207	17	21	and	and	CCONJ
admet-207	17	22	“	"	PUNCT
admet-207	17	23	meros	meros	PROPN
admet-207	17	24	,	,	PUNCT
admet-207	17	25	”	"	PUNCT
admet-207	17	26	(	(	PUNCT
admet-207	17	27	part	part	NOUN
admet-207	17	28	)	)	PUNCT
admet-207	17	29	was	be	AUX
admet-207	17	30	first	first	ADV
admet-207	17	31	named	name	VERB
admet-207	17	32	by	by	ADP
admet-207	17	33	american	american	PROPN
admet-207	17	34	geneticist	geneticist	PROPN
admet-207	17	35	hermann	hermann	PROPN
admet-207	17	36	j.	j.	PROPN
admet-207	17	37	muller	muller	PROPN
admet-207	17	38	,	,	PUNCT
admet-207	17	39	who	who	PRON
admet-207	17	40	observed	observe	VERB
admet-207	17	41	through	through	ADP
admet-207	17	42	mutation	mutation	NOUN
admet-207	17	43	experiments	experiment	NOUN
admet-207	17	44	carried	carry	VERB
admet-207	17	45	out	out	ADP
admet-207	17	46	during	during	ADP
admet-207	17	47	the	the	DET
admet-207	17	48	1930s	1930	NOUN
admet-207	17	49	[	[	X
admet-207	17	50	3	3	NUM
admet-207	17	51	]	]	PUNCT
admet-207	17	52	.	.	PUNCT
admet-207	18	1	telomeres	telomere	NOUN
admet-207	18	2	which	which	PRON
admet-207	18	3	have	have	VERB
admet-207	18	4	specialized	specialized	ADJ
admet-207	18	5	structures	structure	NOUN
admet-207	18	6	that	that	PRON
admet-207	18	7	repeat	repeat	VERB
admet-207	18	8	at	at	ADP
admet-207	18	9	the	the	DET
admet-207	18	10	ends	end	NOUN
admet-207	18	11	of	of	ADP
admet-207	18	12	chromosomes	chromosome	NOUN
admet-207	18	13	are	be	AUX
admet-207	18	14	thought	think	VERB
admet-207	18	15	to	to	PART
admet-207	18	16	be	be	AUX
admet-207	18	17	important	important	ADJ
admet-207	18	18	for	for	ADP
admet-207	18	19	the	the	DET
admet-207	18	20	integrity	integrity	NOUN
admet-207	18	21	and	and	CCONJ
admet-207	18	22	stability	stability	NOUN
admet-207	18	23	of	of	ADP
admet-207	18	24	chromosomes	chromosome	NOUN
admet-207	18	25	.	.	PUNCT
admet-207	19	1	this	this	DET
admet-207	19	2	observation	observation	NOUN
admet-207	19	3	implied	imply	VERB
admet-207	19	4	that	that	SCONJ
admet-207	19	5	cells	cell	NOUN
admet-207	19	6	contained	contain	VERB
admet-207	19	7	an	an	DET
admet-207	19	8	http://www.pub.iapchem.org/ojs/index.php/admet/index	http://www.pub.iapchem.org/ojs/index.php/admet/index	NOUN
admet-207	19	9	mailto:cxqyguestc@163.com	mailto:cxqyguestc@163.com	X
admet-207	19	10	admet	admet	PROPN
admet-207	19	11	&	&	CCONJ
admet-207	19	12	dmpk	dmpk	PROPN
admet-207	19	13	3(3	3(3	NUM
admet-207	19	14	)	)	PUNCT
admet-207	19	15	(	(	PUNCT
admet-207	19	16	2015	2015	NUM
admet-207	19	17	)	)	PUNCT
admet-207	19	18	254	254	NUM
admet-207	19	19	-	-	SYM
admet-207	19	20	259	259	NUM
admet-207	19	21	telomere	telomere	NOUN
admet-207	19	22	and	and	CCONJ
admet-207	19	23	telomerase	telomerase	NOUN
admet-207	19	24	in	in	ADP
admet-207	19	25	degenerative	degenerative	ADJ
admet-207	19	26	diseases	disease	NOUN
admet-207	19	27	doi	doi	NOUN
admet-207	19	28	:	:	PUNCT
admet-207	19	29	10.5599	10.5599	NUM
admet-207	19	30	/	/	SYM
admet-207	19	31	admet.3.3.207	admet.3.3.207	PROPN
admet-207	19	32	255	255	NUM
admet-207	19	33	enzyme	enzyme	NOUN
admet-207	19	34	that	that	PRON
admet-207	19	35	could	could	AUX
admet-207	19	36	catalyze	catalyze	VERB
admet-207	19	37	the	the	DET
admet-207	19	38	lengthening	lengthening	NOUN
admet-207	19	39	of	of	ADP
admet-207	19	40	chromosomal	chromosomal	ADJ
admet-207	19	41	ends	end	NOUN
admet-207	19	42	.	.	PUNCT
admet-207	20	1	in	in	ADP
admet-207	20	2	1984	1984	NUM
admet-207	20	3	,	,	PUNCT
admet-207	20	4	elizabeth	elizabeth	PROPN
admet-207	20	5	blackburn	blackburn	PROPN
admet-207	20	6	discovered	discover	VERB
admet-207	20	7	the	the	DET
admet-207	20	8	enzyme	enzyme	NOUN
admet-207	20	9	telomerase	telomerase	NOUN
admet-207	20	10	in	in	ADP
admet-207	20	11	the	the	DET
admet-207	20	12	ciliate	ciliate	ADJ
admet-207	20	13	tetrahymena	tetrahymena	NOUN
admet-207	20	14	,	,	PUNCT
admet-207	20	15	which	which	PRON
admet-207	20	16	has	have	VERB
admet-207	20	17	the	the	DET
admet-207	20	18	ability	ability	NOUN
admet-207	20	19	to	to	PART
admet-207	20	20	lengthen	lengthen	VERB
admet-207	20	21	chromosomal	chromosomal	ADJ
admet-207	20	22	ends	end	NOUN
admet-207	20	23	by	by	ADP
admet-207	20	24	its	its	PRON
admet-207	20	25	reverse	reverse	ADJ
admet-207	20	26	transcriptase	transcriptase	NOUN
admet-207	20	27	activity	activity	NOUN
admet-207	20	28	[	[	X
admet-207	20	29	4	4	NUM
admet-207	20	30	]	]	PUNCT
admet-207	20	31	.	.	PUNCT
admet-207	21	1	telomeres	telomere	NOUN
admet-207	21	2	dna	dna	PROPN
admet-207	21	3	sequences	sequence	NOUN
admet-207	21	4	are	be	AUX
admet-207	21	5	highly	highly	ADV
admet-207	21	6	conservative	conservative	ADJ
admet-207	21	7	and	and	CCONJ
admet-207	21	8	genus	genus	NOUN
admet-207	21	9	-	-	PUNCT
admet-207	21	10	species	species	NOUN
admet-207	21	11	specific	specific	ADJ
admet-207	21	12	.	.	PUNCT
admet-207	22	1	human	human	ADJ
admet-207	22	2	telomeres	telomere	NOUN
admet-207	22	3	contain	contain	VERB
admet-207	22	4	an	an	DET
admet-207	22	5	array	array	NOUN
admet-207	22	6	of	of	ADP
admet-207	22	7	tandem	tandem	PROPN
admet-207	22	8	dna	dna	PROPN
admet-207	22	9	repeats	repeat	NOUN
admet-207	22	10	(	(	PUNCT
admet-207	22	11	5’-ttaggg-3	5’-ttaggg-3	NUM
admet-207	22	12	’	'	PUNCT
admet-207	22	13	)	)	PUNCT
admet-207	22	14	,	,	PUNCT
admet-207	22	15	which	which	PRON
admet-207	22	16	do	do	AUX
admet-207	22	17	not	not	PART
admet-207	22	18	encode	encode	VERB
admet-207	22	19	any	any	DET
admet-207	22	20	gene	gene	NOUN
admet-207	22	21	product	product	NOUN
admet-207	22	22	.	.	PUNCT
admet-207	23	1	the	the	DET
admet-207	23	2	length	length	NOUN
admet-207	23	3	of	of	ADP
admet-207	23	4	the	the	DET
admet-207	23	5	telomere	telomere	PROPN
admet-207	23	6	dna	dna	PROPN
admet-207	23	7	repeats	repeat	VERB
admet-207	23	8	varies	vary	VERB
admet-207	23	9	from	from	ADP
admet-207	23	10	about	about	ADP
admet-207	23	11	5～15kp	5～15kp	NUM
admet-207	23	12	.	.	PUNCT
admet-207	24	1	these	these	DET
admet-207	24	2	special	special	ADJ
admet-207	24	3	dna	dna	PROPN
admet-207	24	4	repeats	repeat	NOUN
admet-207	24	5	combine	combine	VERB
admet-207	24	6	their	their	PRON
admet-207	24	7	associated	associate	VERB
admet-207	24	8	proteins	protein	NOUN
admet-207	24	9	to	to	PART
admet-207	24	10	form	form	VERB
admet-207	24	11	the	the	DET
admet-207	24	12	cap	cap	NOUN
admet-207	24	13	of	of	ADP
admet-207	24	14	chromosomes	chromosome	NOUN
admet-207	24	15	,	,	PUNCT
admet-207	24	16	which	which	PRON
admet-207	24	17	can	can	AUX
admet-207	24	18	prevent	prevent	VERB
admet-207	24	19	chromosome	chromosome	NOUN
admet-207	24	20	end	end	NOUN
admet-207	24	21	-	-	PUNCT
admet-207	24	22	to	to	ADP
admet-207	24	23	-	-	PUNCT
admet-207	24	24	end	end	NOUN
admet-207	24	25	fusion	fusion	NOUN
admet-207	24	26	,	,	PUNCT
admet-207	24	27	degradation	degradation	NOUN
admet-207	24	28	and	and	CCONJ
admet-207	24	29	rearrangement	rearrangement	NOUN
admet-207	24	30	from	from	ADP
admet-207	24	31	happening	happen	VERB
admet-207	24	32	,	,	PUNCT
admet-207	24	33	unless	unless	SCONJ
admet-207	24	34	the	the	DET
admet-207	24	35	free	free	ADJ
admet-207	24	36	ends	end	NOUN
admet-207	24	37	of	of	ADP
admet-207	24	38	the	the	DET
admet-207	24	39	dna	dna	PROPN
admet-207	24	40	molecule	molecule	NOUN
admet-207	24	41	are	be	AUX
admet-207	24	42	processed	process	VERB
admet-207	24	43	as	as	ADV
admet-207	24	44	double	double	ADJ
admet-207	24	45	stranded	strand	VERB
admet-207	24	46	breaks	break	NOUN
admet-207	24	47	[	[	X
admet-207	24	48	5	5	NUM
admet-207	24	49	]	]	PUNCT
admet-207	24	50	.	.	PUNCT
admet-207	25	1	to	to	PART
admet-207	25	2	avoid	avoid	VERB
admet-207	25	3	chromosome	chromosome	NOUN
admet-207	25	4	damage	damage	NOUN
admet-207	25	5	,	,	PUNCT
admet-207	25	6	the	the	DET
admet-207	25	7	end	end	NOUN
admet-207	25	8	of	of	ADP
admet-207	25	9	telomeres	telomere	NOUN
admet-207	25	10	forms	form	VERB
admet-207	25	11	two	two	NUM
admet-207	25	12	internal	internal	ADJ
admet-207	25	13	loops	loop	NOUN
admet-207	25	14	(	(	PUNCT
admet-207	25	15	d	d	NOUN
admet-207	25	16	-	-	PUNCT
admet-207	25	17	loop	loop	NOUN
admet-207	25	18	and	and	CCONJ
admet-207	25	19	t	t	NOUN
admet-207	25	20	-	-	PUNCT
admet-207	25	21	loop	loop	NOUN
admet-207	25	22	)	)	PUNCT
admet-207	25	23	with	with	ADP
admet-207	25	24	the	the	DET
admet-207	25	25	participation	participation	NOUN
admet-207	25	26	of	of	ADP
admet-207	25	27	the	the	DET
admet-207	25	28	shelterin	shelterin	NOUN
admet-207	25	29	complex	complex	NOUN
admet-207	26	1	[	[	X
admet-207	26	2	6	6	NUM
admet-207	26	3	]	]	PUNCT
admet-207	26	4	.	.	PUNCT
admet-207	27	1	usually	usually	ADV
admet-207	27	2	the	the	DET
admet-207	27	3	shelterin	shelterin	PROPN
admet-207	27	4	complex	complex	NOUN
admet-207	27	5	is	be	AUX
admet-207	27	6	made	make	VERB
admet-207	27	7	up	up	ADP
admet-207	27	8	of	of	ADP
admet-207	27	9	six	six	NUM
admet-207	27	10	proteins	protein	NOUN
admet-207	27	11	which	which	PRON
admet-207	27	12	play	play	VERB
admet-207	27	13	different	different	ADJ
admet-207	27	14	roles	role	NOUN
admet-207	27	15	,	,	PUNCT
admet-207	27	16	including	include	VERB
admet-207	27	17	telomeric	telomeric	ADJ
admet-207	27	18	repeat	repeat	NOUN
admet-207	27	19	-	-	PUNCT
admet-207	27	20	binding	bind	VERB
admet-207	27	21	factors	factor	NOUN
admet-207	27	22	1	1	NUM
admet-207	27	23	and	and	CCONJ
admet-207	27	24	2	2	NUM
admet-207	27	25	(	(	PUNCT
admet-207	27	26	trf1	trf1	NOUN
admet-207	27	27	and	and	CCONJ
admet-207	27	28	trf2	trf2	PROPN
admet-207	27	29	)	)	PUNCT
admet-207	27	30	,	,	PUNCT
admet-207	27	31	trf1	trf1	NOUN
admet-207	27	32	-	-	PUNCT
admet-207	27	33	interacting	interact	VERB
admet-207	27	34	nuclear	nuclear	ADJ
admet-207	27	35	factor	factor	NOUN
admet-207	27	36	2	2	NUM
admet-207	27	37	(	(	PUNCT
admet-207	27	38	tin2	tin2	PROPN
admet-207	27	39	)	)	PUNCT
admet-207	27	40	,	,	PUNCT
admet-207	27	41	repressor	repressor	NOUN
admet-207	27	42	activator	activator	NOUN
admet-207	27	43	protein	protein	NOUN
admet-207	27	44	1	1	NUM
admet-207	27	45	(	(	PUNCT
admet-207	27	46	rap1	rap1	PROPN
admet-207	27	47	)	)	PUNCT
admet-207	27	48	,	,	PUNCT
admet-207	27	49	tin2	tin2	NOUN
admet-207	27	50	-	-	PUNCT
admet-207	27	51	interacting	interact	VERB
admet-207	27	52	protein	protein	NOUN
admet-207	27	53	1	1	NUM
admet-207	27	54	(	(	PUNCT
admet-207	27	55	tint1	tint1	NOUN
admet-207	27	56	)	)	PUNCT
admet-207	27	57	and	and	CCONJ
admet-207	27	58	protection	protection	NOUN
admet-207	27	59	of	of	ADP
admet-207	27	60	telomeres	telomere	NOUN
admet-207	27	61	1	1	NUM
admet-207	27	62	protein	protein	NOUN
admet-207	27	63	(	(	PUNCT
admet-207	27	64	pot1	pot1	PROPN
admet-207	27	65	)	)	PUNCT
admet-207	27	66	.	.	PUNCT
admet-207	28	1	trf1	trf1	NOUN
admet-207	28	2	and	and	CCONJ
admet-207	28	3	trf2	trf2	NOUN
admet-207	28	4	bind	bind	NOUN
admet-207	28	5	to	to	ADP
admet-207	28	6	double	double	VERB
admet-207	28	7	stranded	strand	VERB
admet-207	28	8	ttaggg	ttaggg	NOUN
admet-207	28	9	repeats	repeat	NOUN
admet-207	28	10	,	,	PUNCT
admet-207	28	11	and	and	CCONJ
admet-207	28	12	the	the	DET
admet-207	28	13	pot1	pot1	PROPN
admet-207	28	14	binds	bind	VERB
admet-207	28	15	to	to	ADP
admet-207	28	16	the	the	DET
admet-207	28	17	3	3	NUM
admet-207	28	18	’	'	PUNCT
admet-207	28	19	g	g	NOUN
admet-207	28	20	-	-	PUNCT
admet-207	28	21	rich	rich	ADJ
admet-207	28	22	overhang	overhang	NOUN
admet-207	28	23	.	.	PUNCT
admet-207	29	1	the	the	DET
admet-207	29	2	three	three	NUM
admet-207	29	3	remaining	remain	VERB
admet-207	29	4	factors	factor	NOUN
admet-207	29	5	contained	contain	VERB
admet-207	29	6	tin2	tin2	NOUN
admet-207	29	7	,	,	PUNCT
admet-207	29	8	rap1	rap1	NOUN
admet-207	29	9	and	and	CCONJ
admet-207	29	10	tint1	tint1	PROPN
admet-207	29	11	,	,	PUNCT
admet-207	29	12	which	which	PRON
admet-207	29	13	interact	interact	VERB
admet-207	29	14	with	with	ADP
admet-207	29	15	the	the	DET
admet-207	29	16	telomere	telomere	NOUN
admet-207	29	17	-	-	PUNCT
admet-207	29	18	bound	bind	VERB
admet-207	29	19	proteins	protein	NOUN
admet-207	29	20	to	to	PART
admet-207	29	21	form	form	VERB
admet-207	29	22	a	a	DET
admet-207	29	23	complex	complex	NOUN
admet-207	29	24	.	.	PUNCT
admet-207	30	1	this	this	PRON
admet-207	30	2	allows	allow	VERB
admet-207	30	3	cells	cell	NOUN
admet-207	30	4	to	to	PART
admet-207	30	5	distinguish	distinguish	VERB
admet-207	30	6	telomeres	telomere	NOUN
admet-207	30	7	from	from	ADP
admet-207	30	8	sites	site	NOUN
admet-207	30	9	of	of	ADP
admet-207	30	10	dna	dna	PROPN
admet-207	30	11	damage	damage	NOUN
admet-207	30	12	[	[	X
admet-207	30	13	7	7	NUM
admet-207	30	14	-	-	SYM
admet-207	30	15	9	9	NUM
admet-207	30	16	]	]	PUNCT
admet-207	30	17	.	.	PUNCT
admet-207	31	1	telomeres	telomere	NOUN
admet-207	31	2	maintain	maintain	VERB
admet-207	31	3	the	the	DET
admet-207	31	4	integrity	integrity	NOUN
admet-207	31	5	of	of	ADP
admet-207	31	6	chromosomes	chromosome	NOUN
admet-207	31	7	.	.	PUNCT
admet-207	32	1	as	as	SCONJ
admet-207	32	2	the	the	DET
admet-207	32	3	cell	cell	NOUN
admet-207	32	4	divides	divide	VERB
admet-207	32	5	,	,	PUNCT
admet-207	32	6	about	about	ADV
admet-207	32	7	100	100	NUM
admet-207	32	8	-	-	SYM
admet-207	32	9	200	200	NUM
admet-207	32	10	bp	bp	NOUN
admet-207	32	11	of	of	ADP
admet-207	32	12	telomeric	telomeric	ADJ
admet-207	32	13	dna	dna	PROPN
admet-207	32	14	sequence	sequence	NOUN
admet-207	32	15	is	be	AUX
admet-207	32	16	lost	lose	VERB
admet-207	32	17	.	.	PUNCT
admet-207	33	1	this	this	DET
admet-207	33	2	phenomenon	phenomenon	NOUN
admet-207	33	3	is	be	AUX
admet-207	33	4	so	so	ADV
admet-207	33	5	-	-	PUNCT
admet-207	33	6	called	call	VERB
admet-207	33	7	the	the	DET
admet-207	33	8	“	"	PUNCT
admet-207	33	9	end	end	NOUN
admet-207	33	10	replication	replication	NOUN
admet-207	33	11	problem	problem	NOUN
admet-207	33	12	”	"	PUNCT
admet-207	33	13	.	.	PUNCT
admet-207	34	1	when	when	SCONJ
admet-207	34	2	the	the	DET
admet-207	34	3	dna	dna	NOUN
admet-207	34	4	repeats	repeat	VERB
admet-207	34	5	strand	strand	NOUN
admet-207	34	6	becomes	become	VERB
admet-207	34	7	too	too	ADV
admet-207	34	8	short	short	ADJ
admet-207	34	9	to	to	PART
admet-207	34	10	form	form	VERB
admet-207	34	11	loops	loop	NOUN
admet-207	34	12	,	,	PUNCT
admet-207	34	13	the	the	DET
admet-207	34	14	chromosome	chromosome	NOUN
admet-207	34	15	loses	lose	VERB
admet-207	34	16	its	its	PRON
admet-207	34	17	endpoint	endpoint	NOUN
admet-207	34	18	protection	protection	NOUN
admet-207	34	19	[	[	X
admet-207	34	20	9	9	NUM
admet-207	34	21	]	]	PUNCT
admet-207	34	22	.	.	PUNCT
admet-207	35	1	this	this	PRON
admet-207	35	2	is	be	AUX
admet-207	35	3	why	why	SCONJ
admet-207	35	4	the	the	DET
admet-207	35	5	telomeric	telomeric	ADJ
admet-207	35	6	repeats	repeat	NOUN
admet-207	35	7	shorten	shorten	VERB
admet-207	35	8	progressively	progressively	ADV
admet-207	35	9	with	with	ADP
admet-207	35	10	each	each	DET
admet-207	35	11	cell	cell	NOUN
admet-207	35	12	division	division	NOUN
admet-207	35	13	[	[	X
admet-207	35	14	10	10	NUM
admet-207	35	15	]	]	PUNCT
admet-207	35	16	.	.	PUNCT
admet-207	36	1	if	if	SCONJ
admet-207	36	2	the	the	DET
admet-207	36	3	telomeres	telomere	NOUN
admet-207	36	4	are	be	AUX
admet-207	36	5	shortened	shorten	VERB
admet-207	36	6	enough	enough	ADV
admet-207	36	7	,	,	PUNCT
admet-207	36	8	telomerase	telomerase	NOUN
admet-207	36	9	is	be	AUX
admet-207	36	10	activated	activate	VERB
admet-207	36	11	to	to	PART
admet-207	36	12	compensate	compensate	VERB
admet-207	36	13	for	for	ADP
admet-207	36	14	the	the	DET
admet-207	36	15	end	end	NOUN
admet-207	36	16	-	-	PUNCT
admet-207	36	17	replication	replication	NOUN
admet-207	36	18	problem	problem	NOUN
admet-207	36	19	[	[	X
admet-207	36	20	11	11	NUM
admet-207	36	21	]	]	PUNCT
admet-207	36	22	,	,	PUNCT
admet-207	36	23	so	so	SCONJ
admet-207	36	24	that	that	SCONJ
admet-207	36	25	the	the	DET
admet-207	36	26	length	length	NOUN
admet-207	36	27	of	of	ADP
admet-207	36	28	telomeres	telomere	NOUN
admet-207	36	29	is	be	AUX
admet-207	36	30	maintained	maintain	VERB
admet-207	36	31	.	.	PUNCT
admet-207	37	1	human	human	ADJ
admet-207	37	2	telomerase	telomerase	NOUN
admet-207	37	3	which	which	PRON
admet-207	37	4	is	be	AUX
admet-207	37	5	a	a	DET
admet-207	37	6	ribonucleoprotein	ribonucleoprotein	NOUN
admet-207	37	7	polymerase	polymerase	NOUN
admet-207	37	8	(	(	PUNCT
admet-207	37	9	rnp	rnp	PROPN
admet-207	37	10	)	)	PUNCT
admet-207	37	11	composed	compose	VERB
admet-207	37	12	of	of	ADP
admet-207	37	13	an	an	DET
admet-207	37	14	essential	essential	ADJ
admet-207	37	15	rna	rna	NOUN
admet-207	37	16	and	and	CCONJ
admet-207	37	17	associated	associate	VERB
admet-207	37	18	proteins	protein	NOUN
admet-207	37	19	has	have	VERB
admet-207	37	20	important	important	ADJ
admet-207	37	21	function	function	NOUN
admet-207	37	22	.	.	PUNCT
admet-207	38	1	when	when	SCONJ
admet-207	38	2	chromosome	chromosome	NOUN
admet-207	38	3	loses	lose	VERB
admet-207	38	4	its	its	PRON
admet-207	38	5	endpoint	endpoint	NOUN
admet-207	38	6	protection	protection	NOUN
admet-207	38	7	,	,	PUNCT
admet-207	38	8	telomerase	telomerase	NOUN
admet-207	38	9	is	be	AUX
admet-207	38	10	activated	activate	VERB
admet-207	38	11	to	to	PART
admet-207	38	12	catalyze	catalyze	VERB
admet-207	38	13	the	the	DET
admet-207	38	14	addition	addition	NOUN
admet-207	38	15	of	of	ADP
admet-207	38	16	ttaggg	ttaggg	NOUN
admet-207	38	17	nucleotide	nucleotide	NOUN
admet-207	38	18	repeats	repeat	NOUN
admet-207	38	19	to	to	ADP
admet-207	38	20	the	the	DET
admet-207	38	21	3	3	NUM
admet-207	38	22	’	'	PUNCT
admet-207	38	23	terminus	terminus	NOUN
admet-207	38	24	of	of	ADP
admet-207	38	25	the	the	DET
admet-207	38	26	chromosome	chromosome	NOUN
admet-207	38	27	’s	’s	PART
admet-207	38	28	dna	dna	NOUN
admet-207	39	1	[	[	X
admet-207	39	2	12	12	NUM
admet-207	39	3	]	]	PUNCT
admet-207	39	4	,	,	PUNCT
admet-207	39	5	so	so	SCONJ
admet-207	39	6	that	that	SCONJ
admet-207	39	7	it	it	PRON
admet-207	39	8	guarantees	guarantee	VERB
admet-207	39	9	the	the	DET
admet-207	39	10	length	length	NOUN
admet-207	39	11	and	and	CCONJ
admet-207	39	12	function	function	NOUN
admet-207	39	13	of	of	ADP
admet-207	39	14	telomeres	telomere	NOUN
admet-207	39	15	.	.	PUNCT
admet-207	40	1	in	in	ADP
admet-207	40	2	generally	generally	ADV
admet-207	40	3	,	,	PUNCT
admet-207	40	4	the	the	DET
admet-207	40	5	telomerase	telomerase	NOUN
admet-207	40	6	holoenzyme	holoenzyme	NOUN
admet-207	40	7	consists	consist	VERB
admet-207	40	8	of	of	ADP
admet-207	40	9	three	three	NUM
admet-207	40	10	components	component	NOUN
admet-207	40	11	:	:	PUNCT
admet-207	40	12	telomerase	telomerase	NOUN
admet-207	40	13	reverse	reverse	ADJ
admet-207	40	14	transcriptase	transcriptase	NOUN
admet-207	40	15	(	(	PUNCT
admet-207	40	16	tert	tert	NOUN
admet-207	40	17	)	)	PUNCT
admet-207	40	18	,	,	PUNCT
admet-207	40	19	the	the	DET
admet-207	40	20	telomerase	telomerase	NOUN
admet-207	40	21	rna	rna	NOUN
admet-207	40	22	component	component	NOUN
admet-207	40	23	(	(	PUNCT
admet-207	40	24	terc	terc	PROPN
admet-207	40	25	)	)	PUNCT
admet-207	40	26	and	and	CCONJ
admet-207	40	27	telomerase	telomerase	VERB
admet-207	40	28	related	relate	VERB
admet-207	40	29	proteins	protein	NOUN
admet-207	40	30	(	(	PUNCT
admet-207	40	31	tep	tep	NOUN
admet-207	40	32	)	)	PUNCT
admet-207	40	33	.	.	PUNCT
admet-207	41	1	the	the	DET
admet-207	41	2	tert	tert	NOUN
admet-207	41	3	and	and	CCONJ
admet-207	41	4	terc	terc	NOUN
admet-207	41	5	are	be	AUX
admet-207	41	6	most	most	ADV
admet-207	41	7	important	important	ADJ
admet-207	41	8	.	.	PUNCT
admet-207	42	1	terc	terc	NOUN
admet-207	42	2	as	as	ADP
admet-207	42	3	a	a	DET
admet-207	42	4	template	template	NOUN
admet-207	42	5	can	can	AUX
admet-207	42	6	add	add	VERB
admet-207	42	7	a	a	DET
admet-207	42	8	ttaggg	ttaggg	NOUN
admet-207	42	9	nucleotide	nucleotide	NOUN
admet-207	42	10	repeat	repeat	VERB
admet-207	42	11	to	to	ADP
admet-207	42	12	the	the	DET
admet-207	42	13	3	3	NUM
admet-207	42	14	’	'	PUNCT
admet-207	42	15	end	end	NOUN
admet-207	42	16	of	of	ADP
admet-207	42	17	the	the	DET
admet-207	42	18	telomere	telomere	PROPN
admet-207	42	19	’s	’s	PART
admet-207	42	20	leading	lead	VERB
admet-207	42	21	strand	strand	NOUN
admet-207	42	22	;	;	PUNCT
admet-207	42	23	tert	tert	NOUN
admet-207	42	24	is	be	AUX
admet-207	42	25	taken	take	VERB
admet-207	42	26	to	to	PART
admet-207	42	27	be	be	AUX
admet-207	42	28	the	the	DET
admet-207	42	29	rate	rate	NOUN
admet-207	42	30	-	-	PUNCT
admet-207	42	31	limiting	limit	VERB
admet-207	42	32	component	component	NOUN
admet-207	42	33	of	of	ADP
admet-207	42	34	telomerase	telomerase	NOUN
admet-207	42	35	activity	activity	NOUN
admet-207	43	1	[	[	X
admet-207	43	2	13	13	NUM
admet-207	43	3	]	]	PUNCT
admet-207	43	4	.	.	PUNCT
admet-207	44	1	terc	terc	PROPN
admet-207	44	2	varies	vary	VERB
admet-207	44	3	greatly	greatly	ADV
admet-207	44	4	among	among	ADP
admet-207	44	5	species	specie	NOUN
admet-207	44	6	,	,	PUNCT
admet-207	44	7	but	but	CCONJ
admet-207	44	8	tert	tert	NOUN
admet-207	44	9	is	be	AUX
admet-207	44	10	relatively	relatively	ADV
admet-207	44	11	conserved	conserved	ADJ
admet-207	44	12	throughout	throughout	ADP
admet-207	44	13	evolution	evolution	NOUN
admet-207	44	14	[	[	X
admet-207	44	15	14	14	NUM
admet-207	44	16	]	]	PUNCT
admet-207	44	17	.	.	PUNCT
admet-207	45	1	in	in	ADP
admet-207	45	2	humans	human	NOUN
admet-207	45	3	,	,	PUNCT
admet-207	45	4	terc	terc	NOUN
admet-207	45	5	contains	contain	VERB
admet-207	45	6	451	451	NUM
admet-207	45	7	nucleotides	nucleotide	NOUN
admet-207	45	8	,	,	PUNCT
admet-207	45	9	which	which	PRON
admet-207	45	10	includes	include	VERB
admet-207	45	11	an	an	DET
admet-207	45	12	11	11	NUM
admet-207	45	13	-	-	PUNCT
admet-207	45	14	nucleotide	nucleotide	NOUN
admet-207	45	15	template	template	NOUN
admet-207	45	16	and	and	CCONJ
admet-207	45	17	several	several	ADJ
admet-207	45	18	conserved	conserved	ADJ
admet-207	45	19	regions	region	NOUN
admet-207	45	20	[	[	X
admet-207	45	21	13,15	13,15	NUM
admet-207	45	22	]	]	PUNCT
admet-207	45	23	.	.	PUNCT
admet-207	46	1	it	it	PRON
admet-207	46	2	can	can	AUX
admet-207	46	3	provide	provide	VERB
admet-207	46	4	the	the	DET
admet-207	46	5	template	template	NOUN
admet-207	46	6	for	for	ADP
admet-207	46	7	the	the	DET
admet-207	46	8	synthesis	synthesis	NOUN
admet-207	46	9	of	of	ADP
admet-207	46	10	telomere	telomere	PROPN
admet-207	46	11	dna	dna	PROPN
admet-207	46	12	repeats	repeat	NOUN
admet-207	46	13	,	,	PUNCT
admet-207	46	14	and	and	CCONJ
admet-207	46	15	also	also	ADV
admet-207	46	16	plays	play	VERB
admet-207	46	17	essential	essential	ADJ
admet-207	46	18	roles	role	NOUN
admet-207	46	19	in	in	ADP
admet-207	46	20	catalysis	catalysis	NOUN
admet-207	46	21	and	and	CCONJ
admet-207	46	22	accumulation	accumulation	NOUN
admet-207	46	23	of	of	ADP
admet-207	46	24	telomerase	telomerase	NOUN
admet-207	46	25	rnp	rnp	PROPN
admet-207	46	26	.	.	PUNCT
admet-207	47	1	the	the	DET
admet-207	47	2	tert	tert	NOUN
admet-207	47	3	gene	gene	NOUN
admet-207	47	4	which	which	PRON
admet-207	47	5	located	locate	VERB
admet-207	47	6	on	on	ADP
admet-207	47	7	chromosome	chromosome	NOUN
admet-207	47	8	5	5	NUM
admet-207	47	9	,	,	PUNCT
admet-207	47	10	consists	consist	VERB
admet-207	47	11	of	of	ADP
admet-207	47	12	16	16	NUM
admet-207	47	13	exons	exon	NOUN
admet-207	47	14	and	and	CCONJ
admet-207	47	15	15	15	NUM
admet-207	47	16	introns	intron	NOUN
admet-207	47	17	spanning	span	VERB
admet-207	47	18	35	35	NUM
admet-207	47	19	kb	kb	NOUN
admet-207	47	20	,	,	PUNCT
admet-207	47	21	including	include	VERB
admet-207	47	22	330	330	NUM
admet-207	47	23	base	base	NOUN
admet-207	47	24	pairs	pair	NOUN
admet-207	47	25	upstream	upstream	ADV
admet-207	47	26	of	of	ADP
admet-207	47	27	the	the	DET
admet-207	47	28	translation	translation	NOUN
admet-207	47	29	start	start	VERB
admet-207	47	30	site	site	NOUN
admet-207	47	31	,	,	PUNCT
admet-207	47	32	as	as	ADV
admet-207	47	33	well	well	ADV
admet-207	47	34	as	as	ADP
admet-207	47	35	37	37	NUM
admet-207	47	36	base	base	NOUN
admet-207	47	37	pairs	pair	NOUN
admet-207	47	38	of	of	ADP
admet-207	47	39	exon	exon	NOUN
admet-207	47	40	2	2	NUM
admet-207	47	41	of	of	ADP
admet-207	47	42	the	the	DET
admet-207	47	43	tert	tert	NOUN
admet-207	47	44	gene	gene	NOUN
admet-207	47	45	.	.	PUNCT
admet-207	48	1	the	the	DET
admet-207	48	2	tert	tert	NOUN
admet-207	48	3	promoter	promoter	NOUN
admet-207	48	4	which	which	PRON
admet-207	48	5	contains	contain	VERB
admet-207	48	6	many	many	ADJ
admet-207	48	7	sites	site	NOUN
admet-207	48	8	for	for	ADP
admet-207	48	9	several	several	ADJ
admet-207	48	10	transcription	transcription	NOUN
admet-207	48	11	factors	factor	NOUN
admet-207	48	12	is	be	AUX
admet-207	48	13	gc	gc	ADJ
admet-207	48	14	-	-	ADJ
admet-207	48	15	rich	rich	ADJ
admet-207	48	16	and	and	CCONJ
admet-207	48	17	lacks	lack	VERB
admet-207	48	18	tata	tata	NOUN
admet-207	48	19	and	and	CCONJ
admet-207	48	20	caat	caat	PROPN
admet-207	48	21	.	.	PUNCT
admet-207	49	1	it	it	PRON
admet-207	49	2	is	be	AUX
admet-207	49	3	an	an	DET
admet-207	49	4	important	important	ADJ
admet-207	49	5	target	target	NOUN
admet-207	49	6	for	for	ADP
admet-207	49	7	therapy	therapy	NOUN
admet-207	49	8	of	of	ADP
admet-207	49	9	cancer	cancer	NOUN
admet-207	49	10	and	and	CCONJ
admet-207	49	11	degenerative	degenerative	ADJ
admet-207	49	12	diseases	disease	NOUN
admet-207	49	13	.	.	PUNCT
admet-207	50	1	telomerase	telomerase	NOUN
admet-207	50	2	has	have	VERB
admet-207	50	3	other	other	ADJ
admet-207	50	4	related	relate	VERB
admet-207	50	5	proteins	protein	NOUN
admet-207	50	6	(	(	PUNCT
admet-207	50	7	tep	tep	NOUN
admet-207	50	8	)	)	PUNCT
admet-207	50	9	,	,	PUNCT
admet-207	50	10	such	such	ADJ
admet-207	50	11	as	as	ADP
admet-207	50	12	gar1	gar1	NOUN
admet-207	50	13	,	,	PUNCT
admet-207	50	14	nhp2	nhp2	NOUN
admet-207	50	15	and	and	CCONJ
admet-207	50	16	nop10	nop10	PROPN
admet-207	50	17	.	.	PUNCT
admet-207	51	1	they	they	PRON
admet-207	51	2	are	be	AUX
admet-207	51	3	assembled	assemble	VERB
admet-207	51	4	in	in	ADP
admet-207	51	5	the	the	DET
admet-207	51	6	telomerase	telomerase	NOUN
admet-207	51	7	complex	complex	NOUN
admet-207	51	8	and	and	CCONJ
admet-207	51	9	play	play	VERB
admet-207	51	10	distinctive	distinctive	ADJ
admet-207	51	11	roles	role	NOUN
admet-207	51	12	in	in	ADP
admet-207	51	13	telomerase	telomerase	NOUN
admet-207	51	14	function	function	NOUN
admet-207	51	15	[	[	X
admet-207	51	16	16	16	NUM
admet-207	51	17	]	]	PUNCT
admet-207	51	18	.	.	PUNCT
admet-207	52	1	the	the	DET
admet-207	52	2	role	role	NOUN
admet-207	52	3	of	of	ADP
admet-207	52	4	telomere	telomere	NOUN
admet-207	52	5	and	and	CCONJ
admet-207	52	6	telomerase	telomerase	NOUN
admet-207	52	7	in	in	ADP
admet-207	52	8	degenerative	degenerative	ADJ
admet-207	52	9	diseases	disease	NOUN
admet-207	52	10	telomere	telomere	ADV
admet-207	52	11	length	length	NOUN
admet-207	52	12	shortening	shortening	NOUN
admet-207	52	13	has	have	AUX
admet-207	52	14	been	be	AUX
admet-207	52	15	evidenced	evidence	VERB
admet-207	52	16	as	as	ADP
admet-207	52	17	not	not	PART
admet-207	52	18	only	only	ADV
admet-207	52	19	a	a	DET
admet-207	52	20	marker	marker	NOUN
admet-207	52	21	of	of	ADP
admet-207	52	22	biological	biological	ADJ
admet-207	52	23	aging	aging	NOUN
admet-207	52	24	but	but	CCONJ
admet-207	52	25	also	also	ADV
admet-207	52	26	a	a	DET
admet-207	52	27	mechanism	mechanism	NOUN
admet-207	52	28	with	with	ADP
admet-207	52	29	important	important	ADJ
admet-207	52	30	functional	functional	ADJ
admet-207	52	31	consequences	consequence	NOUN
admet-207	52	32	.	.	PUNCT
admet-207	53	1	it	it	PRON
admet-207	53	2	has	have	AUX
admet-207	53	3	been	be	AUX
admet-207	53	4	considered	consider	VERB
admet-207	53	5	as	as	ADP
admet-207	53	6	a	a	DET
admet-207	53	7	risk	risk	NOUN
admet-207	53	8	factor	factor	NOUN
admet-207	53	9	for	for	ADP
admet-207	53	10	multiple	multiple	ADJ
admet-207	53	11	aging	age	VERB
admet-207	53	12	-	-	PUNCT
admet-207	53	13	associated	associate	VERB
admet-207	53	14	diseases	disease	NOUN
admet-207	53	15	and	and	CCONJ
admet-207	53	16	conditions	condition	NOUN
admet-207	53	17	.	.	PUNCT
admet-207	54	1	the	the	DET
admet-207	54	2	study	study	NOUN
admet-207	54	3	of	of	ADP
admet-207	54	4	telomere	telomere	NOUN
admet-207	54	5	and	and	CCONJ
admet-207	54	6	telomerase	telomerase	NOUN
admet-207	54	7	biology	biology	NOUN
admet-207	54	8	shows	show	VERB
admet-207	54	9	a	a	DET
admet-207	54	10	higher	high	ADJ
admet-207	54	11	prevalence	prevalence	NOUN
admet-207	54	12	of	of	ADP
admet-207	54	13	development	development	NOUN
admet-207	54	14	in	in	ADP
admet-207	54	15	many	many	ADJ
admet-207	54	16	neurodegenerative	neurodegenerative	ADJ
admet-207	54	17	diseases	disease	NOUN
admet-207	54	18	,	,	PUNCT
admet-207	54	19	such	such	ADJ
admet-207	54	20	as	as	ADP
admet-207	54	21	alzheimer	alzheimer	PROPN
admet-207	54	22	’s	’s	PART
admet-207	54	23	disease	disease	NOUN
admet-207	54	24	(	(	PUNCT
admet-207	54	25	ad	ad	NOUN
admet-207	54	26	)	)	PUNCT
admet-207	54	27	,	,	PUNCT
admet-207	54	28	c.	c.	PROPN
admet-207	54	29	li	li	PROPN
admet-207	54	30	and	and	CCONJ
admet-207	54	31	y.	y.	PROPN
admet-207	54	32	gang	gang	PROPN
admet-207	54	33	admet	admet	PROPN
admet-207	54	34	&	&	CCONJ
admet-207	54	35	dmpk	dmpk	PROPN
admet-207	54	36	3(3	3(3	NUM
admet-207	54	37	)	)	PUNCT
admet-207	54	38	(	(	PUNCT
admet-207	54	39	2015	2015	NUM
admet-207	54	40	)	)	PUNCT
admet-207	54	41	254	254	NUM
admet-207	54	42	-	-	SYM
admet-207	54	43	259	259	NUM
admet-207	54	44	256	256	NUM
admet-207	54	45	parkinson	parkinson	NOUN
admet-207	54	46	’s	’s	PART
admet-207	54	47	disease	disease	NOUN
admet-207	54	48	(	(	PUNCT
admet-207	54	49	pd	pd	NOUN
admet-207	54	50	)	)	PUNCT
admet-207	54	51	,	,	PUNCT
admet-207	54	52	cvd	cvd	PROPN
admet-207	54	53	,	,	PUNCT
admet-207	54	54	hypertension	hypertension	NOUN
admet-207	54	55	,	,	PUNCT
admet-207	54	56	atherosclerosis	atherosclerosis	NOUN
admet-207	54	57	,	,	PUNCT
admet-207	54	58	heart	heart	NOUN
admet-207	54	59	failure	failure	NOUN
admet-207	54	60	,	,	PUNCT
admet-207	54	61	diabetes	diabetes	NOUN
admet-207	54	62	and	and	CCONJ
admet-207	54	63	so	so	ADV
admet-207	54	64	on	on	ADV
admet-207	54	65	.	.	PUNCT
admet-207	55	1	this	this	DET
admet-207	55	2	review	review	NOUN
admet-207	55	3	focuses	focus	VERB
admet-207	55	4	on	on	ADP
admet-207	55	5	providing	provide	VERB
admet-207	55	6	a	a	DET
admet-207	55	7	general	general	ADJ
admet-207	55	8	understanding	understanding	NOUN
admet-207	55	9	of	of	ADP
admet-207	55	10	the	the	DET
admet-207	55	11	role	role	NOUN
admet-207	55	12	of	of	ADP
admet-207	55	13	telomere	telomere	NOUN
admet-207	55	14	and	and	CCONJ
admet-207	55	15	telomerase	telomerase	NOUN
admet-207	55	16	in	in	ADP
admet-207	55	17	alzheimer	alzheimer	PROPN
admet-207	55	18	’s	’s	PART
admet-207	55	19	disease	disease	NOUN
admet-207	55	20	(	(	PUNCT
admet-207	55	21	ad	ad	NOUN
admet-207	55	22	)	)	PUNCT
admet-207	55	23	and	and	CCONJ
admet-207	55	24	parkinson	parkinson	NOUN
admet-207	55	25	’s	’s	PART
admet-207	55	26	disease	disease	NOUN
admet-207	55	27	(	(	PUNCT
admet-207	55	28	pd	pd	NOUN
admet-207	55	29	)	)	PUNCT
admet-207	55	30	.	.	PUNCT
admet-207	56	1	alzheimer	alzheimer	PROPN
admet-207	56	2	’s	’s	PART
admet-207	56	3	disease	disease	NOUN
admet-207	56	4	and	and	CCONJ
admet-207	56	5	parkinson	parkinson	NOUN
admet-207	56	6	’s	’s	PART
admet-207	56	7	disease	disease	NOUN
admet-207	56	8	are	be	AUX
admet-207	56	9	the	the	DET
admet-207	56	10	two	two	NUM
admet-207	56	11	main	main	ADJ
admet-207	56	12	aging	age	VERB
admet-207	56	13	-	-	PUNCT
admet-207	56	14	associated	associate	VERB
admet-207	56	15	progressive	progressive	ADJ
admet-207	56	16	neurodegenerative	neurodegenerative	ADJ
admet-207	56	17	disorders	disorder	NOUN
admet-207	56	18	.	.	PUNCT
admet-207	57	1	studies	study	NOUN
admet-207	57	2	show	show	VERB
admet-207	57	3	that	that	SCONJ
admet-207	57	4	they	they	PRON
admet-207	57	5	are	be	AUX
admet-207	57	6	related	relate	VERB
admet-207	57	7	to	to	ADP
admet-207	57	8	telomere	telomere	NOUN
admet-207	57	9	and	and	CCONJ
admet-207	57	10	telomerase	telomerase	NOUN
admet-207	57	11	.	.	PUNCT
admet-207	58	1	the	the	DET
admet-207	58	2	relationship	relationship	NOUN
admet-207	58	3	between	between	ADP
admet-207	58	4	telomere	telomere	NOUN
admet-207	58	5	shortening	shortening	NOUN
admet-207	58	6	and	and	CCONJ
admet-207	58	7	ad	ad	NOUN
admet-207	58	8	has	have	AUX
admet-207	58	9	been	be	AUX
admet-207	58	10	studied	study	VERB
admet-207	58	11	using	use	VERB
admet-207	58	12	in	in	ADP
admet-207	58	13	vitro	vitro	X
admet-207	58	14	and	and	CCONJ
admet-207	58	15	in	in	ADP
admet-207	58	16	vivo	vivo	NOUN
admet-207	58	17	models	model	NOUN
admet-207	58	18	in	in	ADP
admet-207	58	19	ad	ad	NOUN
admet-207	58	20	patients	patient	NOUN
admet-207	58	21	.	.	PUNCT
admet-207	59	1	oxidative	oxidative	ADJ
admet-207	59	2	stress	stress	NOUN
admet-207	59	3	is	be	AUX
admet-207	59	4	regarded	regard	VERB
admet-207	59	5	as	as	ADP
admet-207	59	6	the	the	DET
admet-207	59	7	most	most	ADV
admet-207	59	8	important	important	ADJ
admet-207	59	9	influencing	influence	VERB
admet-207	59	10	factor	factor	NOUN
admet-207	59	11	of	of	ADP
admet-207	59	12	telomere	telomere	PROPN
admet-207	59	13	shortening	shortening	NOUN
admet-207	59	14	.	.	PUNCT
admet-207	60	1	there	there	PRON
admet-207	60	2	are	be	VERB
admet-207	60	3	some	some	DET
admet-207	60	4	studies	study	NOUN
admet-207	60	5	connecting	connect	VERB
admet-207	60	6	the	the	DET
admet-207	60	7	telomere	telomere	NOUN
admet-207	60	8	length	length	NOUN
admet-207	60	9	to	to	ADP
admet-207	60	10	alzheimer	alzheimer	PROPN
admet-207	60	11	’s	’s	PART
admet-207	60	12	disease	disease	NOUN
admet-207	60	13	.	.	PUNCT
admet-207	61	1	panossian	panossian	PROPN
admet-207	61	2	l.	l.	PROPN
admet-207	61	3	a.	a.	PROPN
admet-207	61	4	et	et	PROPN
admet-207	61	5	al	al	PROPN
admet-207	61	6	.	.	PUNCT
admet-207	62	1	[	[	X
admet-207	62	2	17	17	NUM
admet-207	62	3	]	]	PUNCT
admet-207	62	4	first	first	ADV
admet-207	62	5	found	find	VERB
admet-207	62	6	that	that	SCONJ
admet-207	62	7	patients	patient	NOUN
admet-207	62	8	with	with	ADP
admet-207	62	9	ad	ad	NOUN
admet-207	62	10	had	have	VERB
admet-207	62	11	shorter	short	ADJ
admet-207	62	12	telomere	telomere	NOUN
admet-207	62	13	lengths	length	NOUN
admet-207	62	14	in	in	ADP
admet-207	62	15	peripheral	peripheral	ADJ
admet-207	62	16	blood	blood	NOUN
admet-207	62	17	mononuclear	mononuclear	ADJ
admet-207	62	18	cells	cell	NOUN
admet-207	62	19	than	than	ADP
admet-207	62	20	that	that	PRON
admet-207	62	21	of	of	ADP
admet-207	62	22	the	the	DET
admet-207	62	23	age	age	NOUN
admet-207	62	24	-	-	PUNCT
admet-207	62	25	matched	match	VERB
admet-207	62	26	control	control	NOUN
admet-207	62	27	subjects	subject	NOUN
admet-207	62	28	.	.	PUNCT
admet-207	63	1	then	then	ADV
admet-207	63	2	,	,	PUNCT
admet-207	63	3	jenkins	jenkins	PROPN
admet-207	63	4	e.	e.	PROPN
admet-207	63	5	c	c	PROPN
admet-207	63	6	et	et	PROPN
admet-207	63	7	al	al	PROPN
admet-207	63	8	.	.	PUNCT
admet-207	64	1	[	[	X
admet-207	64	2	18	18	NUM
admet-207	64	3	]	]	PUNCT
admet-207	64	4	found	find	VERB
admet-207	64	5	that	that	SCONJ
admet-207	64	6	older	old	ADJ
admet-207	64	7	females	female	NOUN
admet-207	64	8	with	with	ADP
admet-207	64	9	down	down	ADP
admet-207	64	10	syndrome	syndrome	NOUN
admet-207	64	11	and	and	CCONJ
admet-207	64	12	ad	ad	NOUN
admet-207	64	13	-	-	PUNCT
admet-207	64	14	type	type	NOUN
admet-207	64	15	dementia	dementia	NOUN
admet-207	64	16	had	have	VERB
admet-207	64	17	shorter	short	ADJ
admet-207	64	18	t	t	NOUN
admet-207	64	19	-	-	PUNCT
admet-207	64	20	cell	cell	NOUN
admet-207	64	21	telomeres	telomere	NOUN
admet-207	64	22	than	than	ADP
admet-207	64	23	that	that	PRON
admet-207	64	24	of	of	ADP
admet-207	64	25	the	the	DET
admet-207	64	26	age	age	NOUN
admet-207	64	27	-	-	PUNCT
admet-207	64	28	matched	match	VERB
admet-207	64	29	counterpart	counterpart	NOUN
admet-207	64	30	.	.	PUNCT
admet-207	65	1	moreover	moreover	ADV
admet-207	65	2	,	,	PUNCT
admet-207	65	3	a	a	DET
admet-207	65	4	case	case	NOUN
admet-207	65	5	control	control	NOUN
admet-207	65	6	study	study	NOUN
admet-207	65	7	of	of	ADP
admet-207	65	8	257	257	NUM
admet-207	65	9	individuals	individual	NOUN
admet-207	65	10	revealed	reveal	VERB
admet-207	65	11	a	a	DET
admet-207	65	12	shortened	shorten	VERB
admet-207	65	13	peripheral	peripheral	ADJ
admet-207	65	14	blood	blood	NOUN
admet-207	65	15	leukocyte	leukocyte	NOUN
admet-207	65	16	(	(	PUNCT
admet-207	65	17	pbl	pbl	NOUN
admet-207	65	18	)	)	PUNCT
admet-207	65	19	telomere	telomere	NOUN
admet-207	65	20	length	length	NOUN
admet-207	65	21	in	in	ADP
admet-207	65	22	ad	ad	NOUN
admet-207	65	23	patients	patient	NOUN
admet-207	65	24	compared	compare	VERB
admet-207	65	25	with	with	ADP
admet-207	65	26	control	control	NOUN
admet-207	65	27	subjects	subject	NOUN
admet-207	65	28	[	[	X
admet-207	65	29	19	19	NUM
admet-207	65	30	]	]	PUNCT
admet-207	65	31	.	.	PUNCT
admet-207	66	1	and	and	CCONJ
admet-207	66	2	among	among	ADP
admet-207	66	3	individuals	individual	NOUN
admet-207	66	4	with	with	ADP
admet-207	66	5	ad	ad	NOUN
admet-207	66	6	,	,	PUNCT
admet-207	66	7	short	short	ADJ
admet-207	66	8	telomeres	telomere	NOUN
admet-207	66	9	were	be	AUX
admet-207	66	10	associated	associate	VERB
admet-207	66	11	with	with	ADP
admet-207	66	12	higher	high	ADJ
admet-207	66	13	mortality	mortality	NOUN
admet-207	66	14	rates	rate	NOUN
admet-207	66	15	.	.	PUNCT
admet-207	67	1	another	another	DET
admet-207	67	2	study	study	NOUN
admet-207	67	3	confirmed	confirm	VERB
admet-207	67	4	the	the	DET
admet-207	67	5	association	association	NOUN
admet-207	67	6	between	between	ADP
admet-207	67	7	short	short	ADJ
admet-207	67	8	pbl	pbl	PROPN
admet-207	67	9	telomere	telomere	PROPN
admet-207	67	10	length	length	NOUN
admet-207	67	11	and	and	CCONJ
admet-207	67	12	ad	ad	NOUN
admet-207	67	13	,	,	PUNCT
admet-207	67	14	and	and	CCONJ
admet-207	67	15	was	be	AUX
admet-207	67	16	the	the	DET
admet-207	67	17	first	first	ADJ
admet-207	67	18	to	to	PART
admet-207	67	19	examine	examine	VERB
admet-207	67	20	hippocampus	hippocampus	NOUN
admet-207	67	21	telomere	telomere	NOUN
admet-207	67	22	length	length	NOUN
admet-207	67	23	in	in	ADP
admet-207	67	24	histopathologically	histopathologically	ADV
admet-207	67	25	validated	validate	VERB
admet-207	67	26	ad	ad	NOUN
admet-207	67	27	patients	patient	NOUN
admet-207	67	28	[	[	X
admet-207	67	29	20	20	NUM
admet-207	67	30	]	]	PUNCT
admet-207	67	31	.	.	PUNCT
admet-207	68	1	surprisingly	surprisingly	ADV
admet-207	68	2	,	,	PUNCT
admet-207	68	3	telomere	telomere	NOUN
admet-207	68	4	lengths	length	NOUN
admet-207	68	5	in	in	ADP
admet-207	68	6	the	the	DET
admet-207	68	7	hippocampus	hippocampus	NOUN
admet-207	68	8	were	be	AUX
admet-207	68	9	found	find	VERB
admet-207	68	10	to	to	PART
admet-207	68	11	be	be	AUX
admet-207	68	12	49	49	NUM
admet-207	68	13	%	%	NOUN
admet-207	68	14	longer	long	ADV
admet-207	68	15	in	in	ADP
admet-207	68	16	ad	ad	NOUN
admet-207	68	17	patients	patient	NOUN
admet-207	68	18	than	than	ADP
admet-207	68	19	in	in	ADP
admet-207	68	20	control	control	NOUN
admet-207	68	21	subjects	subject	NOUN
admet-207	68	22	(	(	PUNCT
admet-207	68	23	p<0.01	p<0.01	PROPN
admet-207	68	24	)	)	PUNCT
admet-207	68	25	.	.	PUNCT
admet-207	69	1	recently	recently	ADV
admet-207	69	2	,	,	PUNCT
admet-207	69	3	j.	j.	PROPN
admet-207	69	4	nicholas	nicholas	PROPN
admet-207	69	5	lukens	lukens	PROPN
admet-207	69	6	compared	compare	VERB
admet-207	69	7	the	the	DET
admet-207	69	8	telomere	telomere	NOUN
admet-207	69	9	lengths	length	NOUN
admet-207	69	10	in	in	ADP
admet-207	69	11	peripheral	peripheral	ADJ
admet-207	69	12	blood	blood	NOUN
admet-207	69	13	and	and	CCONJ
admet-207	69	14	cerebellum	cerebellum	NOUN
admet-207	69	15	in	in	ADP
admet-207	69	16	alzheimer	alzheimer	PROPN
admet-207	69	17	’s	’s	PART
admet-207	69	18	disease	disease	NOUN
admet-207	69	19	and	and	CCONJ
admet-207	69	20	found	find	VERB
admet-207	69	21	that	that	SCONJ
admet-207	69	22	reduced	reduce	VERB
admet-207	69	23	pbl	pbl	PROPN
admet-207	69	24	telomere	telomere	PROPN
admet-207	69	25	length	length	NOUN
admet-207	69	26	in	in	ADP
admet-207	69	27	ad	ad	NOUN
admet-207	69	28	might	might	AUX
admet-207	69	29	not	not	PART
admet-207	69	30	reflect	reflect	VERB
admet-207	69	31	reduced	reduce	VERB
admet-207	69	32	telomere	telomere	PROPN
admet-207	69	33	length	length	NOUN
admet-207	69	34	in	in	ADP
admet-207	69	35	bulk	bulk	ADJ
admet-207	69	36	brain	brain	NOUN
admet-207	69	37	tissue	tissue	NOUN
admet-207	69	38	,	,	PUNCT
admet-207	69	39	but	but	CCONJ
admet-207	69	40	may	may	AUX
admet-207	69	41	be	be	AUX
admet-207	69	42	a	a	DET
admet-207	69	43	marker	marker	NOUN
admet-207	69	44	of	of	ADP
admet-207	69	45	changes	change	NOUN
admet-207	69	46	in	in	ADP
admet-207	69	47	a	a	DET
admet-207	69	48	subset	subset	NOUN
admet-207	69	49	of	of	ADP
admet-207	69	50	brain	brain	NOUN
admet-207	69	51	tissues	tissue	NOUN
admet-207	69	52	or	or	CCONJ
admet-207	69	53	other	other	ADJ
admet-207	69	54	tissues	tissue	NOUN
admet-207	69	55	that	that	PRON
admet-207	69	56	affect	affect	VERB
admet-207	69	57	the	the	DET
admet-207	69	58	pathogenesis	pathogenesis	NOUN
admet-207	69	59	of	of	ADP
admet-207	69	60	ad	ad	NOUN
admet-207	69	61	[	[	X
admet-207	69	62	21	21	NUM
admet-207	69	63	]	]	PUNCT
admet-207	69	64	.	.	PUNCT
admet-207	70	1	telomerase	telomerase	NOUN
admet-207	70	2	activity	activity	NOUN
admet-207	70	3	in	in	ADP
admet-207	70	4	ad	ad	NOUN
admet-207	70	5	patients	patient	NOUN
admet-207	70	6	was	be	AUX
admet-207	70	7	significantly	significantly	ADV
admet-207	70	8	elevated	elevate	VERB
admet-207	70	9	compared	compare	VERB
admet-207	70	10	with	with	ADP
admet-207	70	11	healthy	healthy	ADJ
admet-207	70	12	controls	control	NOUN
admet-207	70	13	and	and	CCONJ
admet-207	70	14	vascular	vascular	ADJ
admet-207	70	15	dementia	dementia	NOUN
admet-207	70	16	patients	patient	NOUN
admet-207	70	17	,	,	PUNCT
admet-207	70	18	possibly	possibly	ADV
admet-207	70	19	as	as	ADP
admet-207	70	20	a	a	DET
admet-207	70	21	response	response	NOUN
admet-207	70	22	to	to	ADP
admet-207	70	23	the	the	DET
admet-207	70	24	telomere	telomere	NOUN
admet-207	70	25	erosion	erosion	NOUN
admet-207	70	26	accompanying	accompany	VERB
admet-207	70	27	the	the	DET
admet-207	70	28	disease	disease	NOUN
admet-207	70	29	.	.	PUNCT
admet-207	71	1	in	in	ADP
admet-207	71	2	addition	addition	NOUN
admet-207	71	3	,	,	PUNCT
admet-207	71	4	the	the	DET
admet-207	71	5	telomerase	telomerase	NOUN
admet-207	71	6	activity	activity	NOUN
admet-207	71	7	of	of	ADP
admet-207	71	8	lymphocytes	lymphocyte	NOUN
admet-207	71	9	was	be	AUX
admet-207	71	10	significantly	significantly	ADV
admet-207	71	11	correlated	correlate	VERB
admet-207	71	12	with	with	ADP
admet-207	71	13	the	the	DET
admet-207	71	14	degree	degree	NOUN
admet-207	71	15	of	of	ADP
admet-207	71	16	dementia	dementia	NOUN
admet-207	71	17	in	in	ADP
admet-207	71	18	ad	ad	NOUN
admet-207	71	19	patients	patient	NOUN
admet-207	71	20	,	,	PUNCT
admet-207	71	21	suggesting	suggest	VERB
admet-207	71	22	an	an	DET
admet-207	71	23	accelerated	accelerated	ADJ
admet-207	71	24	telomere	telomere	NOUN
admet-207	71	25	dysfunction	dysfunction	NOUN
admet-207	71	26	in	in	ADP
admet-207	71	27	lymphocytes	lymphocyte	NOUN
admet-207	71	28	and	and	CCONJ
admet-207	71	29	impaired	impaired	ADJ
admet-207	71	30	immune	immune	ADJ
admet-207	71	31	function	function	NOUN
admet-207	71	32	of	of	ADP
admet-207	71	33	ad	ad	NOUN
admet-207	71	34	patients	patient	NOUN
admet-207	71	35	.	.	PUNCT
admet-207	72	1	the	the	DET
admet-207	72	2	relationship	relationship	NOUN
admet-207	72	3	between	between	ADP
admet-207	72	4	telomere	telomere	PROPN
admet-207	72	5	and	and	CCONJ
admet-207	72	6	pd	pd	PROPN
admet-207	72	7	is	be	AUX
admet-207	72	8	not	not	PART
admet-207	72	9	well	well	ADV
admet-207	72	10	clear	clear	ADJ
admet-207	72	11	.	.	PUNCT
admet-207	73	1	several	several	ADJ
admet-207	73	2	studies	study	NOUN
admet-207	73	3	have	have	AUX
admet-207	73	4	shown	show	VERB
admet-207	73	5	that	that	SCONJ
admet-207	73	6	telomere	telomere	NOUN
admet-207	73	7	and	and	CCONJ
admet-207	73	8	telomerase	telomerase	NOUN
admet-207	73	9	are	be	AUX
admet-207	73	10	related	relate	VERB
admet-207	73	11	to	to	ADP
admet-207	73	12	pd	pd	PROPN
admet-207	73	13	,	,	PUNCT
admet-207	73	14	but	but	CCONJ
admet-207	73	15	other	other	ADJ
admet-207	73	16	studies	study	NOUN
admet-207	73	17	indicate	indicate	VERB
admet-207	73	18	that	that	SCONJ
admet-207	73	19	there	there	PRON
admet-207	73	20	are	be	VERB
admet-207	73	21	no	no	DET
admet-207	73	22	evidence	evidence	NOUN
admet-207	73	23	for	for	ADP
admet-207	73	24	short	short	ADJ
admet-207	73	25	telomere	telomere	NOUN
admet-207	73	26	length	length	NOUN
admet-207	73	27	in	in	ADP
admet-207	73	28	pd	pd	PROPN
admet-207	73	29	.	.	PROPN
admet-207	74	1	wang	wang	PROPN
admet-207	74	2	et	et	PROPN
admet-207	74	3	al	al	PROPN
admet-207	74	4	.	.	PUNCT
admet-207	75	1	[	[	X
admet-207	75	2	22	22	NUM
admet-207	75	3	]	]	PUNCT
admet-207	75	4	proved	prove	VERB
admet-207	75	5	that	that	SCONJ
admet-207	75	6	men	man	NOUN
admet-207	75	7	with	with	ADP
admet-207	75	8	shorter	short	ADJ
admet-207	75	9	telomeres	telomere	NOUN
admet-207	75	10	had	have	VERB
admet-207	75	11	a	a	DET
admet-207	75	12	lower	low	ADJ
admet-207	75	13	risk	risk	NOUN
admet-207	75	14	for	for	ADP
admet-207	75	15	pd	pd	PROPN
admet-207	75	16	,	,	PUNCT
admet-207	75	17	which	which	PRON
admet-207	75	18	was	be	AUX
admet-207	75	19	in	in	ADP
admet-207	75	20	marked	marked	ADJ
admet-207	75	21	contrast	contrast	NOUN
admet-207	75	22	with	with	ADP
admet-207	75	23	the	the	DET
admet-207	75	24	observations	observation	NOUN
admet-207	75	25	in	in	ADP
admet-207	75	26	other	other	ADJ
admet-207	75	27	aging	age	VERB
admet-207	75	28	-	-	PUNCT
admet-207	75	29	related	relate	VERB
admet-207	75	30	diseases	disease	NOUN
admet-207	75	31	.	.	PUNCT
admet-207	76	1	in	in	ADP
admet-207	76	2	a	a	DET
admet-207	76	3	study	study	NOUN
admet-207	76	4	of	of	ADP
admet-207	76	5	28	28	NUM
admet-207	76	6	japanese	japanese	ADJ
admet-207	76	7	male	male	ADJ
admet-207	76	8	pd	pd	PROPN
admet-207	76	9	patients	patient	NOUN
admet-207	76	10	,	,	PUNCT
admet-207	76	11	leucocyte	leucocyte	PROPN
admet-207	76	12	telomere	telomere	PROPN
admet-207	76	13	length	length	NOUN
admet-207	76	14	in	in	ADP
admet-207	76	15	pd	pd	PROPN
admet-207	76	16	patients	patient	NOUN
admet-207	76	17	was	be	AUX
admet-207	76	18	not	not	PART
admet-207	76	19	significant	significant	ADJ
admet-207	76	20	different	different	ADJ
admet-207	76	21	from	from	ADP
admet-207	76	22	those	those	PRON
admet-207	76	23	in	in	ADP
admet-207	76	24	controls	control	NOUN
admet-207	76	25	.	.	PUNCT
admet-207	77	1	but	but	CCONJ
admet-207	77	2	mean	mean	VERB
admet-207	77	3	telomere	telomere	PROPN
admet-207	77	4	length	length	NOUN
admet-207	77	5	in	in	ADP
admet-207	77	6	pd	pd	PROPN
admet-207	77	7	patients	patient	NOUN
admet-207	77	8	was	be	AUX
admet-207	77	9	found	find	VERB
admet-207	77	10	to	to	PART
admet-207	77	11	be	be	AUX
admet-207	77	12	5	5	NUM
admet-207	77	13	kb	kb	NOUN
admet-207	77	14	shorter	short	ADJ
admet-207	77	15	suggesting	suggest	VERB
admet-207	77	16	telomere	telomere	NOUN
admet-207	77	17	shortening	shortening	NOUN
admet-207	77	18	was	be	AUX
admet-207	77	19	accelerated	accelerate	VERB
admet-207	77	20	in	in	ADP
admet-207	77	21	pd	pd	PROPN
admet-207	77	22	patients	patient	NOUN
admet-207	78	1	[	[	X
admet-207	78	2	23	23	NUM
admet-207	78	3	]	]	PUNCT
admet-207	78	4	.	.	PUNCT
admet-207	79	1	additionally	additionally	ADV
admet-207	79	2	,	,	PUNCT
admet-207	79	3	maede	maede	NOUN
admet-207	79	4	et	et	NOUN
admet-207	79	5	al	al	PROPN
admet-207	79	6	.	.	PUNCT
admet-207	80	1	[	[	X
admet-207	80	2	24	24	NUM
admet-207	80	3	]	]	PUNCT
admet-207	80	4	investigated	investigate	VERB
admet-207	80	5	the	the	DET
admet-207	80	6	age	age	NOUN
admet-207	80	7	-	-	PUNCT
admet-207	80	8	associated	associate	VERB
admet-207	80	9	alterations	alteration	NOUN
admet-207	80	10	of	of	ADP
admet-207	80	11	subtelomeric	subtelomeric	ADJ
admet-207	80	12	methylation	methylation	NOUN
admet-207	80	13	in	in	ADP
admet-207	80	14	japanese	japanese	ADJ
admet-207	80	15	pd	pd	PROPN
admet-207	80	16	patients	patient	NOUN
admet-207	80	17	.	.	PUNCT
admet-207	81	1	short	short	ADJ
admet-207	81	2	telomeres	telomere	NOUN
admet-207	81	3	with	with	ADP
admet-207	81	4	hypomethylated	hypomethylated	ADJ
admet-207	81	5	subtelomeres	subtelomere	NOUN
admet-207	81	6	increased	increase	VERB
admet-207	81	7	with	with	ADP
admet-207	81	8	aging	aging	NOUN
admet-207	81	9	in	in	ADP
admet-207	81	10	the	the	DET
admet-207	81	11	healthy	healthy	ADJ
admet-207	81	12	controls	control	NOUN
admet-207	81	13	,	,	PUNCT
admet-207	81	14	but	but	CCONJ
admet-207	81	15	did	do	AUX
admet-207	81	16	not	not	PART
admet-207	81	17	change	change	VERB
admet-207	81	18	in	in	ADP
admet-207	81	19	the	the	DET
admet-207	81	20	pd	pd	PROPN
admet-207	81	21	patients	patient	NOUN
admet-207	81	22	.	.	PUNCT
admet-207	82	1	johanna	johanna	PROPN
admet-207	82	2	eerola	eerola	PROPN
admet-207	82	3	et	et	PROPN
admet-207	82	4	al	al	PROPN
admet-207	82	5	analyzed	analyze	VERB
admet-207	82	6	131	131	NUM
admet-207	82	7	pd	pd	NOUN
admet-207	82	8	patients	patient	NOUN
admet-207	82	9	and	and	CCONJ
admet-207	82	10	115	115	NUM
admet-207	82	11	controls	control	NOUN
admet-207	82	12	.	.	PUNCT
admet-207	83	1	it	it	PRON
admet-207	83	2	was	be	AUX
admet-207	83	3	found	find	VERB
admet-207	83	4	that	that	SCONJ
admet-207	83	5	extremely	extremely	ADV
admet-207	83	6	short	short	ADJ
admet-207	83	7	telomeres	telomere	NOUN
admet-207	83	8	were	be	AUX
admet-207	83	9	not	not	PART
admet-207	83	10	more	more	ADV
admet-207	83	11	frequent	frequent	ADJ
admet-207	83	12	in	in	ADP
admet-207	83	13	pd	pd	PROPN
admet-207	83	14	patients	patient	NOUN
admet-207	83	15	than	than	ADP
admet-207	83	16	in	in	ADP
admet-207	83	17	controls	control	NOUN
admet-207	83	18	,	,	PUNCT
admet-207	83	19	so	so	SCONJ
admet-207	83	20	they	they	PRON
admet-207	83	21	consider	consider	VERB
admet-207	83	22	there	there	PRON
admet-207	83	23	was	be	VERB
admet-207	83	24	no	no	DET
admet-207	83	25	evidence	evidence	NOUN
admet-207	83	26	for	for	ADP
admet-207	83	27	shorter	short	ADJ
admet-207	83	28	leukocyte	leukocyte	NOUN
admet-207	83	29	telomere	telomere	NOUN
admet-207	83	30	length	length	NOUN
admet-207	83	31	in	in	ADP
admet-207	83	32	pd	pd	PROPN
admet-207	84	1	[	[	X
admet-207	84	2	25,26	25,26	NUM
admet-207	84	3	]	]	X
admet-207	84	4	.	.	PUNCT
admet-207	85	1	the	the	DET
admet-207	85	2	role	role	NOUN
admet-207	85	3	of	of	ADP
admet-207	85	4	telomere	telomere	NOUN
admet-207	85	5	and	and	CCONJ
admet-207	85	6	telomerase	telomerase	NOUN
admet-207	85	7	in	in	ADP
admet-207	85	8	neurodegenerative	neurodegenerative	ADJ
admet-207	85	9	diseases	disease	NOUN
admet-207	85	10	is	be	AUX
admet-207	85	11	not	not	PART
admet-207	85	12	fully	fully	ADV
admet-207	85	13	understood	understand	VERB
admet-207	85	14	through	through	ADP
admet-207	85	15	above	above	ADJ
admet-207	85	16	researches	research	NOUN
admet-207	85	17	,	,	PUNCT
admet-207	85	18	despite	despite	SCONJ
admet-207	85	19	the	the	DET
admet-207	85	20	progress	progress	NOUN
admet-207	85	21	made	make	VERB
admet-207	85	22	during	during	ADP
admet-207	85	23	the	the	DET
admet-207	85	24	last	last	ADJ
admet-207	85	25	decade	decade	NOUN
admet-207	85	26	.	.	PUNCT
admet-207	86	1	further	further	ADJ
admet-207	86	2	research	research	NOUN
admet-207	86	3	is	be	AUX
admet-207	86	4	essential	essential	ADJ
admet-207	86	5	to	to	PART
admet-207	86	6	clarify	clarify	VERB
admet-207	86	7	whether	whether	SCONJ
admet-207	86	8	the	the	DET
admet-207	86	9	ad	ad	NOUN
admet-207	86	10	and	and	CCONJ
admet-207	86	11	pd	pd	NOUN
admet-207	86	12	are	be	AUX
admet-207	86	13	triggered	trigger	VERB
admet-207	86	14	by	by	ADP
admet-207	86	15	telomere	telomere	NOUN
admet-207	86	16	shortening	shortening	NOUN
admet-207	86	17	.	.	PUNCT
admet-207	87	1	the	the	DET
admet-207	87	2	role	role	NOUN
admet-207	87	3	of	of	ADP
admet-207	87	4	telomere	telomere	NOUN
admet-207	87	5	and	and	CCONJ
admet-207	87	6	telomerase	telomerase	NOUN
admet-207	87	7	in	in	ADP
admet-207	87	8	cancer	cancer	NOUN
admet-207	87	9	telomere	telomere	PROPN
admet-207	87	10	studies	study	NOUN
admet-207	87	11	in	in	ADP
admet-207	87	12	human	human	ADJ
admet-207	87	13	cancer	cancer	NOUN
admet-207	87	14	have	have	AUX
admet-207	87	15	been	be	AUX
admet-207	87	16	extensively	extensively	ADV
admet-207	87	17	reported	report	VERB
admet-207	87	18	for	for	ADP
admet-207	87	19	diagnostics	diagnostic	NOUN
admet-207	87	20	and	and	CCONJ
admet-207	87	21	prognostics	prognostic	NOUN
admet-207	87	22	.	.	PUNCT
admet-207	88	1	shortened	shorten	VERB
admet-207	88	2	telomere	telomere	PROPN
admet-207	88	3	length	length	NOUN
admet-207	88	4	demonstrates	demonstrate	VERB
admet-207	88	5	a	a	DET
admet-207	88	6	significant	significant	ADJ
admet-207	88	7	association	association	NOUN
admet-207	88	8	with	with	ADP
admet-207	88	9	poor	poor	ADJ
admet-207	88	10	cancer	cancer	NOUN
admet-207	88	11	outcome	outcome	NOUN
admet-207	88	12	[	[	X
admet-207	88	13	27	27	NUM
admet-207	88	14	]	]	PUNCT
admet-207	88	15	.	.	PUNCT
admet-207	89	1	admet	admet	PROPN
admet-207	89	2	&	&	CCONJ
admet-207	89	3	dmpk	dmpk	PROPN
admet-207	89	4	3(3	3(3	NUM
admet-207	89	5	)	)	PUNCT
admet-207	89	6	(	(	PUNCT
admet-207	89	7	2015	2015	NUM
admet-207	89	8	)	)	PUNCT
admet-207	89	9	254	254	NUM
admet-207	89	10	-	-	SYM
admet-207	89	11	259	259	NUM
admet-207	89	12	telomere	telomere	NOUN
admet-207	89	13	and	and	CCONJ
admet-207	89	14	telomerase	telomerase	NOUN
admet-207	89	15	in	in	ADP
admet-207	89	16	degenerative	degenerative	ADJ
admet-207	89	17	diseases	disease	NOUN
admet-207	89	18	doi	doi	NOUN
admet-207	89	19	:	:	PUNCT
admet-207	89	20	10.5599	10.5599	NUM
admet-207	89	21	/	/	SYM
admet-207	89	22	admet.3.3.207	admet.3.3.207	PROPN
admet-207	89	23	257	257	NUM
admet-207	89	24	telomere	telomere	NOUN
admet-207	89	25	maintenance	maintenance	NOUN
admet-207	89	26	is	be	AUX
admet-207	89	27	regarded	regard	VERB
admet-207	89	28	as	as	ADP
admet-207	89	29	an	an	DET
admet-207	89	30	important	important	ADJ
admet-207	89	31	mechanism	mechanism	NOUN
admet-207	89	32	in	in	ADP
admet-207	89	33	evading	evade	VERB
admet-207	89	34	senescence	senescence	NOUN
admet-207	89	35	by	by	ADP
admet-207	89	36	cancer	cancer	NOUN
admet-207	89	37	cells	cell	NOUN
admet-207	89	38	,	,	PUNCT
admet-207	89	39	and	and	CCONJ
admet-207	89	40	the	the	DET
admet-207	89	41	role	role	NOUN
admet-207	89	42	of	of	ADP
admet-207	89	43	dysfunctional	dysfunctional	ADJ
admet-207	89	44	telomere	telomere	NOUN
admet-207	89	45	biology	biology	NOUN
admet-207	89	46	in	in	ADP
admet-207	89	47	cancer	cancer	NOUN
admet-207	89	48	is	be	AUX
admet-207	89	49	acknowledged	acknowledge	VERB
admet-207	89	50	.	.	PUNCT
admet-207	90	1	many	many	ADJ
admet-207	90	2	cancer	cancer	NOUN
admet-207	90	3	cases	case	NOUN
admet-207	90	4	were	be	AUX
admet-207	90	5	initiated	initiate	VERB
admet-207	90	6	by	by	ADP
admet-207	90	7	reactivating	reactivate	VERB
admet-207	90	8	or	or	CCONJ
admet-207	90	9	up	up	ADV
admet-207	90	10	-	-	PUNCT
admet-207	90	11	regulating	regulate	VERB
admet-207	90	12	telomerase	telomerase	NOUN
admet-207	90	13	activity	activity	NOUN
admet-207	90	14	.	.	PUNCT
admet-207	91	1	in	in	ADP
admet-207	91	2	addition	addition	NOUN
admet-207	91	3	,	,	PUNCT
admet-207	91	4	in	in	ADP
admet-207	91	5	many	many	ADJ
admet-207	91	6	types	type	NOUN
admet-207	91	7	of	of	ADP
admet-207	91	8	cancer	cancer	NOUN
admet-207	91	9	cell	cell	NOUN
admet-207	91	10	,	,	PUNCT
admet-207	91	11	there	there	PRON
admet-207	91	12	is	be	VERB
admet-207	91	13	a	a	DET
admet-207	91	14	considerable	considerable	ADJ
admet-207	91	15	shortening	shortening	NOUN
admet-207	91	16	of	of	ADP
admet-207	91	17	telomeres	telomere	NOUN
admet-207	91	18	despite	despite	SCONJ
admet-207	91	19	telomerase	telomerase	NOUN
admet-207	91	20	expression	expression	NOUN
admet-207	91	21	[	[	X
admet-207	91	22	28	28	NUM
admet-207	91	23	-	-	SYM
admet-207	91	24	32	32	NUM
admet-207	91	25	]	]	PUNCT
admet-207	91	26	.	.	PUNCT
admet-207	92	1	based	base	VERB
admet-207	92	2	on	on	ADP
admet-207	92	3	these	these	DET
admet-207	92	4	researches	research	NOUN
admet-207	92	5	,	,	PUNCT
admet-207	92	6	several	several	ADJ
admet-207	92	7	anti	anti	ADJ
admet-207	92	8	-	-	ADJ
admet-207	92	9	cancer	cancer	ADJ
admet-207	92	10	drugs	drug	NOUN
admet-207	92	11	and	and	CCONJ
admet-207	92	12	cancer	cancer	NOUN
admet-207	92	13	vaccines	vaccine	NOUN
admet-207	92	14	that	that	PRON
admet-207	92	15	target	target	VERB
admet-207	92	16	the	the	DET
admet-207	92	17	telomerase	telomerase	NOUN
admet-207	92	18	are	be	AUX
admet-207	92	19	used	use	VERB
admet-207	92	20	now	now	ADV
admet-207	92	21	in	in	ADP
admet-207	92	22	phase	phase	NOUN
admet-207	92	23	iii	iii	NUM
admet-207	92	24	clinical	clinical	ADJ
admet-207	92	25	trials	trial	NOUN
admet-207	92	26	.	.	PUNCT
admet-207	93	1	the	the	DET
admet-207	93	2	relations	relation	NOUN
admet-207	93	3	between	between	ADP
admet-207	93	4	telomere	telomere	NOUN
admet-207	93	5	,	,	PUNCT
admet-207	93	6	telomerase	telomerase	NOUN
admet-207	93	7	and	and	CCONJ
admet-207	93	8	cancer	cancer	NOUN
admet-207	93	9	have	have	AUX
admet-207	93	10	been	be	AUX
admet-207	93	11	a	a	DET
admet-207	93	12	hot	hot	ADJ
admet-207	93	13	research	research	NOUN
admet-207	93	14	topic	topic	NOUN
admet-207	93	15	.	.	PUNCT
admet-207	94	1	cancers	cancer	NOUN
admet-207	94	2	occur	occur	VERB
admet-207	94	3	when	when	SCONJ
admet-207	94	4	a	a	DET
admet-207	94	5	cell	cell	NOUN
admet-207	94	6	acquires	acquire	VERB
admet-207	94	7	multiple	multiple	ADJ
admet-207	94	8	genetic	genetic	ADJ
admet-207	94	9	mutations	mutation	NOUN
admet-207	94	10	which	which	PRON
admet-207	94	11	cause	cause	VERB
admet-207	94	12	the	the	DET
admet-207	94	13	cell	cell	NOUN
admet-207	94	14	to	to	PART
admet-207	94	15	escape	escape	VERB
admet-207	94	16	from	from	ADP
admet-207	94	17	normal	normal	ADJ
admet-207	94	18	controls	control	NOUN
admet-207	94	19	on	on	ADP
admet-207	94	20	replication	replication	NOUN
admet-207	94	21	and	and	CCONJ
admet-207	94	22	migration	migration	NOUN
admet-207	94	23	.	.	PUNCT
admet-207	95	1	once	once	SCONJ
admet-207	95	2	the	the	DET
admet-207	95	3	cells	cell	NOUN
admet-207	95	4	and	and	CCONJ
admet-207	95	5	their	their	PRON
admet-207	95	6	offspring	offspring	NOUN
admet-207	95	7	multiply	multiply	NOUN
admet-207	95	8	uncontrollably	uncontrollably	ADV
admet-207	95	9	,	,	PUNCT
admet-207	95	10	they	they	PRON
admet-207	95	11	can	can	AUX
admet-207	95	12	invade	invade	VERB
admet-207	95	13	and	and	CCONJ
admet-207	95	14	damage	damage	VERB
admet-207	95	15	nearby	nearby	ADJ
admet-207	95	16	tissue	tissue	NOUN
admet-207	95	17	.	.	PUNCT
admet-207	96	1	some	some	PRON
admet-207	96	2	may	may	AUX
admet-207	96	3	also	also	ADV
admet-207	96	4	break	break	VERB
admet-207	96	5	away	away	ADP
admet-207	96	6	and	and	CCONJ
admet-207	96	7	travel	travel	VERB
admet-207	96	8	to	to	ADP
admet-207	96	9	parts	part	NOUN
admet-207	96	10	of	of	ADP
admet-207	96	11	the	the	DET
admet-207	96	12	body	body	NOUN
admet-207	96	13	where	where	SCONJ
admet-207	96	14	they	they	PRON
admet-207	96	15	do	do	AUX
admet-207	96	16	not	not	PART
admet-207	96	17	belong	belong	VERB
admet-207	96	18	,	,	PUNCT
admet-207	96	19	resulting	result	VERB
admet-207	96	20	in	in	ADP
admet-207	96	21	new	new	ADJ
admet-207	96	22	metastases	metastasis	NOUN
admet-207	96	23	at	at	ADP
admet-207	96	24	distant	distant	ADJ
admet-207	96	25	sites	site	NOUN
admet-207	96	26	.	.	PUNCT
admet-207	97	1	the	the	DET
admet-207	97	2	lack	lack	NOUN
admet-207	97	3	of	of	ADP
admet-207	97	4	telomerase	telomerase	NOUN
admet-207	97	5	in	in	ADP
admet-207	97	6	tumor	tumor	NOUN
admet-207	97	7	cells	cell	NOUN
admet-207	97	8	may	may	AUX
admet-207	97	9	slow	slow	VERB
admet-207	97	10	the	the	DET
admet-207	97	11	growth	growth	NOUN
admet-207	97	12	with	with	ADP
admet-207	97	13	dividing	divide	VERB
admet-207	97	14	cells	cell	NOUN
admet-207	97	15	,	,	PUNCT
admet-207	97	16	and	and	CCONJ
admet-207	97	17	lose	lose	VERB
admet-207	97	18	their	their	PRON
admet-207	97	19	telomeres	telomere	NOUN
admet-207	97	20	before	before	SCONJ
admet-207	97	21	they	they	PRON
admet-207	97	22	do	do	VERB
admet-207	97	23	much	much	ADJ
admet-207	97	24	damage	damage	NOUN
admet-207	97	25	.	.	PUNCT
admet-207	98	1	on	on	ADP
admet-207	98	2	the	the	DET
admet-207	98	3	other	other	ADJ
admet-207	98	4	hand	hand	NOUN
admet-207	98	5	,	,	PUNCT
admet-207	98	6	if	if	SCONJ
admet-207	98	7	cancer	cancer	NOUN
admet-207	98	8	cells	cell	NOUN
admet-207	98	9	were	be	AUX
admet-207	98	10	able	able	ADJ
admet-207	98	11	to	to	PART
admet-207	98	12	generate	generate	VERB
admet-207	98	13	telomerase	telomerase	NOUN
admet-207	98	14	,	,	PUNCT
admet-207	98	15	they	they	PRON
admet-207	98	16	could	could	AUX
admet-207	98	17	retain	retain	VERB
admet-207	98	18	telomeres	telomere	NOUN
admet-207	98	19	and	and	CCONJ
admet-207	98	20	might	might	AUX
admet-207	98	21	growth	growth	VERB
admet-207	98	22	indefinitely	indefinitely	ADV
admet-207	98	23	.	.	PUNCT
admet-207	99	1	researchers	researcher	NOUN
admet-207	99	2	suspect	suspect	VERB
admet-207	99	3	that	that	SCONJ
admet-207	99	4	the	the	DET
admet-207	99	5	loss	loss	NOUN
admet-207	99	6	of	of	ADP
admet-207	99	7	proliferative	proliferative	ADJ
admet-207	99	8	capacity	capacity	NOUN
admet-207	99	9	observed	observe	VERB
admet-207	99	10	in	in	ADP
admet-207	99	11	human	human	ADJ
admet-207	99	12	cells	cell	NOUN
admet-207	99	13	that	that	SCONJ
admet-207	99	14	lacking	lack	VERB
admet-207	99	15	telomerase	telomerase	NOUN
admet-207	99	16	may	may	AUX
admet-207	99	17	help	help	VERB
admet-207	99	18	us	we	PRON
admet-207	99	19	to	to	PART
admet-207	99	20	avoid	avoid	VERB
admet-207	99	21	cancer	cancer	NOUN
admet-207	99	22	.	.	PUNCT
admet-207	100	1	here	here	ADV
admet-207	100	2	,	,	PUNCT
admet-207	100	3	we	we	PRON
admet-207	100	4	direct	direct	VERB
admet-207	100	5	our	our	PRON
admet-207	100	6	attention	attention	NOUN
admet-207	100	7	to	to	ADP
admet-207	100	8	digestive	digestive	ADJ
admet-207	100	9	cancers	cancer	NOUN
admet-207	100	10	,	,	PUNCT
admet-207	100	11	telomere	telomere	NOUN
admet-207	100	12	and	and	CCONJ
admet-207	100	13	telomerase	telomerase	NOUN
admet-207	100	14	.	.	PUNCT
admet-207	101	1	telomerase	telomerase	NOUN
admet-207	101	2	activity	activity	NOUN
admet-207	101	3	is	be	AUX
admet-207	101	4	especially	especially	ADV
admet-207	101	5	considered	consider	VERB
admet-207	101	6	as	as	ADP
admet-207	101	7	the	the	DET
admet-207	101	8	most	most	ADV
admet-207	101	9	important	important	ADJ
admet-207	101	10	factor	factor	NOUN
admet-207	101	11	in	in	ADP
admet-207	101	12	carcinogenesis	carcinogenesis	NOUN
admet-207	101	13	,	,	PUNCT
admet-207	101	14	progression	progression	NOUN
admet-207	101	15	and	and	CCONJ
admet-207	101	16	prognosis	prognosis	NOUN
admet-207	101	17	.	.	PUNCT
admet-207	102	1	fundamental	fundamental	ADJ
admet-207	102	2	researches	research	NOUN
admet-207	102	3	showed	show	VERB
admet-207	102	4	that	that	SCONJ
admet-207	102	5	telomerase	telomerase	NOUN
admet-207	102	6	was	be	AUX
admet-207	102	7	activated	activate	VERB
admet-207	102	8	in	in	ADP
admet-207	102	9	various	various	ADJ
admet-207	102	10	cancer	cancer	NOUN
admet-207	102	11	tissues	tissue	NOUN
admet-207	102	12	and	and	CCONJ
admet-207	102	13	cell	cell	NOUN
admet-207	102	14	lines	line	NOUN
admet-207	102	15	[	[	X
admet-207	102	16	33	33	NUM
admet-207	102	17	-	-	SYM
admet-207	102	18	35	35	NUM
admet-207	102	19	]	]	PUNCT
admet-207	102	20	.	.	PUNCT
admet-207	103	1	telomerase	telomerase	NOUN
admet-207	103	2	activity	activity	NOUN
admet-207	103	3	was	be	AUX
admet-207	103	4	shown	show	VERB
admet-207	103	5	to	to	PART
admet-207	103	6	be	be	AUX
admet-207	103	7	positive	positive	ADJ
admet-207	103	8	in	in	ADP
admet-207	103	9	85	85	NUM
admet-207	103	10	%	%	NOUN
admet-207	103	11	～	～	NOUN
admet-207	103	12	100	100	NUM
admet-207	103	13	%	%	NOUN
admet-207	103	14	of	of	ADP
admet-207	103	15	cancer	cancer	NOUN
admet-207	103	16	tissues	tissue	NOUN
admet-207	103	17	and	and	CCONJ
admet-207	103	18	negative	negative	ADJ
admet-207	103	19	in	in	ADP
admet-207	103	20	almost	almost	ADV
admet-207	103	21	all	all	PRON
admet-207	103	22	normal	normal	ADJ
admet-207	103	23	tissues	tissue	NOUN
admet-207	103	24	,	,	PUNCT
admet-207	103	25	except	except	SCONJ
admet-207	103	26	for	for	ADP
admet-207	103	27	reproductive	reproductive	ADJ
admet-207	103	28	and	and	CCONJ
admet-207	103	29	haemopoietic	haemopoietic	ADJ
admet-207	103	30	cells	cell	NOUN
admet-207	103	31	.	.	PUNCT
admet-207	104	1	in	in	ADP
admet-207	104	2	digestive	digestive	ADJ
admet-207	104	3	cancers	cancer	NOUN
admet-207	104	4	,	,	PUNCT
admet-207	104	5	many	many	ADJ
admet-207	104	6	studies	study	NOUN
admet-207	104	7	regard	regard	VERB
admet-207	104	8	telomerase	telomerase	NOUN
admet-207	104	9	activity	activity	NOUN
admet-207	104	10	and	and	CCONJ
admet-207	104	11	telomere	telomere	NOUN
admet-207	104	12	length	length	NOUN
admet-207	104	13	are	be	AUX
admet-207	104	14	associated	associate	VERB
admet-207	104	15	with	with	ADP
admet-207	104	16	the	the	DET
admet-207	104	17	occurrences	occurrence	NOUN
admet-207	104	18	of	of	ADP
admet-207	104	19	cancer	cancer	NOUN
admet-207	104	20	,	,	PUNCT
admet-207	104	21	and	and	CCONJ
admet-207	104	22	as	as	ADP
admet-207	104	23	prognostic	prognostic	ADJ
admet-207	104	24	markers	marker	NOUN
admet-207	104	25	in	in	ADP
admet-207	104	26	malignancies	malignancy	NOUN
admet-207	104	27	.	.	PUNCT
admet-207	105	1	studies	study	NOUN
admet-207	105	2	indicate	indicate	VERB
admet-207	105	3	telomerase	telomerase	NOUN
admet-207	105	4	activity	activity	NOUN
admet-207	105	5	is	be	AUX
admet-207	105	6	detected	detect	VERB
admet-207	105	7	in	in	ADP
admet-207	105	8	85	85	NUM
admet-207	105	9	%	%	NOUN
admet-207	105	10	of	of	ADP
admet-207	105	11	the	the	DET
admet-207	105	12	hepatocellular	hepatocellular	ADJ
admet-207	105	13	carcinoma	carcinoma	NOUN
admet-207	105	14	specimens	specimen	NOUN
admet-207	106	1	[	[	X
admet-207	106	2	36	36	NUM
admet-207	106	3	]	]	PUNCT
admet-207	106	4	,	,	PUNCT
admet-207	106	5	85	85	NUM
admet-207	106	6	%	%	NOUN
admet-207	106	7	～	～	NOUN
admet-207	106	8	88	88	NUM
admet-207	106	9	%	%	NOUN
admet-207	106	10	of	of	ADP
admet-207	106	11	gastric	gastric	ADJ
admet-207	106	12	carcinomatous	carcinomatous	ADJ
admet-207	106	13	tissues	tissue	NOUN
admet-207	107	1	[	[	X
admet-207	107	2	37	37	NUM
admet-207	107	3	]	]	PUNCT
admet-207	107	4	,	,	PUNCT
admet-207	107	5	and	and	CCONJ
admet-207	107	6	90	90	NUM
admet-207	107	7	%	%	NOUN
admet-207	107	8	of	of	ADP
admet-207	107	9	colorectal	colorectal	ADJ
admet-207	107	10	tumors	tumor	NOUN
admet-207	108	1	[	[	X
admet-207	108	2	38	38	NUM
admet-207	108	3	]	]	PUNCT
admet-207	108	4	.	.	PUNCT
admet-207	109	1	in	in	ADP
admet-207	109	2	gastrointestinal	gastrointestinal	ADJ
admet-207	109	3	cancer	cancer	NOUN
admet-207	109	4	,	,	PUNCT
admet-207	109	5	human	human	ADJ
admet-207	109	6	telomerase	telomerase	NOUN
admet-207	109	7	are	be	AUX
admet-207	109	8	expressed	express	VERB
admet-207	109	9	in	in	ADP
admet-207	109	10	various	various	ADJ
admet-207	109	11	levels	level	NOUN
admet-207	109	12	between	between	ADP
admet-207	109	13	all	all	DET
admet-207	109	14	tumor	tumor	NOUN
admet-207	109	15	specimens	specimen	NOUN
admet-207	109	16	and	and	CCONJ
admet-207	109	17	normal	normal	ADJ
admet-207	109	18	mucosa	mucosa	NOUN
admet-207	109	19	.	.	PUNCT
admet-207	110	1	for	for	ADP
admet-207	110	2	instance	instance	NOUN
admet-207	110	3	,	,	PUNCT
admet-207	110	4	the	the	DET
admet-207	110	5	expression	expression	NOUN
admet-207	110	6	of	of	ADP
admet-207	110	7	telomerase	telomerase	NOUN
admet-207	110	8	is	be	AUX
admet-207	110	9	81	81	NUM
admet-207	110	10	%	%	NOUN
admet-207	110	11	higher	high	ADJ
admet-207	110	12	in	in	ADP
admet-207	110	13	the	the	DET
admet-207	110	14	tumor	tumor	NOUN
admet-207	110	15	than	than	ADP
admet-207	110	16	normal	normal	ADJ
admet-207	110	17	mucosa	mucosa	NOUN
admet-207	110	18	.	.	PUNCT
admet-207	111	1	meanwhile	meanwhile	ADV
admet-207	111	2	35	35	NUM
admet-207	111	3	%	%	NOUN
admet-207	111	4	of	of	ADP
admet-207	111	5	normal	normal	ADJ
admet-207	111	6	mucosa	mucosa	NOUN
admet-207	111	7	showed	show	VERB
admet-207	111	8	telomerase	telomerase	NOUN
admet-207	111	9	activity	activity	NOUN
admet-207	111	10	and	and	CCONJ
admet-207	111	11	all	all	PRON
admet-207	111	12	of	of	ADP
admet-207	111	13	them	they	PRON
admet-207	111	14	contained	contain	VERB
admet-207	111	15	intestinal	intestinal	ADJ
admet-207	111	16	metaplasia	metaplasia	NOUN
admet-207	112	1	[	[	X
admet-207	112	2	39,40	39,40	NUM
admet-207	112	3	]	]	PUNCT
admet-207	112	4	.	.	PUNCT
admet-207	113	1	the	the	DET
admet-207	113	2	study	study	NOUN
admet-207	113	3	by	by	ADP
admet-207	113	4	engelhardt	engelhardt	PROPN
admet-207	113	5	m	m	PROPN
admet-207	113	6	indicated	indicate	VERB
admet-207	113	7	that	that	SCONJ
admet-207	113	8	increased	increase	VERB
admet-207	113	9	telomerase	telomerase	NOUN
admet-207	113	10	activity	activity	NOUN
admet-207	113	11	occurs	occur	VERB
admet-207	113	12	in	in	ADP
admet-207	113	13	colon	colon	NOUN
admet-207	113	14	cancer	cancer	NOUN
admet-207	113	15	cells	cell	NOUN
admet-207	113	16	that	that	PRON
admet-207	113	17	have	have	AUX
admet-207	113	18	undergone	undergo	VERB
admet-207	113	19	extensive	extensive	ADJ
admet-207	113	20	telomere	telomere	NOUN
admet-207	113	21	shortening	shorten	VERB
admet-207	113	22	relative	relative	ADJ
admet-207	113	23	to	to	ADP
admet-207	113	24	surrounding	surround	VERB
admet-207	113	25	normal	normal	ADJ
admet-207	113	26	tissues	tissue	NOUN
admet-207	113	27	,	,	PUNCT
admet-207	113	28	in	in	ADP
admet-207	113	29	which	which	DET
admet-207	113	30	telomerase	telomerase	NOUN
admet-207	113	31	-	-	PUNCT
admet-207	113	32	induced	induce	VERB
admet-207	113	33	stabilization	stabilization	NOUN
admet-207	113	34	of	of	ADP
admet-207	113	35	telomeres	telomere	NOUN
admet-207	113	36	may	may	AUX
admet-207	113	37	be	be	AUX
admet-207	113	38	critical	critical	ADJ
admet-207	113	39	for	for	ADP
admet-207	113	40	the	the	DET
admet-207	113	41	continued	continue	VERB
admet-207	113	42	proliferation	proliferation	NOUN
admet-207	113	43	of	of	ADP
admet-207	113	44	the	the	DET
admet-207	113	45	malignant	malignant	ADJ
admet-207	113	46	clone	clone	NOUN
admet-207	114	1	[	[	X
admet-207	114	2	38	38	NUM
admet-207	114	3	]	]	PUNCT
admet-207	114	4	.	.	PUNCT
admet-207	115	1	the	the	DET
admet-207	115	2	link	link	NOUN
admet-207	115	3	between	between	ADP
admet-207	115	4	telomerase	telomerase	NOUN
admet-207	115	5	activity	activity	NOUN
admet-207	115	6	and	and	CCONJ
admet-207	115	7	stage	stage	NOUN
admet-207	115	8	suggests	suggest	VERB
admet-207	115	9	that	that	SCONJ
admet-207	115	10	telomerase	telomerase	NOUN
admet-207	115	11	is	be	AUX
admet-207	115	12	up	up	ADV
admet-207	115	13	-	-	PUNCT
admet-207	115	14	regulated	regulate	VERB
admet-207	115	15	as	as	ADP
admet-207	115	16	a	a	DET
admet-207	115	17	function	function	NOUN
admet-207	115	18	of	of	ADP
admet-207	115	19	increased	increase	VERB
admet-207	115	20	tumor	tumor	NOUN
admet-207	115	21	cell	cell	NOUN
admet-207	115	22	invasion	invasion	NOUN
admet-207	115	23	,	,	PUNCT
admet-207	115	24	tumor	tumor	NOUN
admet-207	115	25	progression	progression	NOUN
admet-207	115	26	,	,	PUNCT
admet-207	115	27	and	and	CCONJ
admet-207	115	28	metastatic	metastatic	ADJ
admet-207	115	29	potential	potential	NOUN
admet-207	115	30	in	in	ADP
admet-207	115	31	colon	colon	NOUN
admet-207	115	32	cancer	cancer	NOUN
admet-207	115	33	.	.	PUNCT
admet-207	116	1	on	on	ADP
admet-207	116	2	the	the	DET
admet-207	116	3	research	research	NOUN
admet-207	116	4	of	of	ADP
admet-207	116	5	prognosis	prognosis	NOUN
admet-207	116	6	,	,	PUNCT
admet-207	116	7	telomere	telomere	NOUN
admet-207	116	8	length	length	NOUN
admet-207	116	9	could	could	AUX
admet-207	116	10	be	be	AUX
admet-207	116	11	a	a	DET
admet-207	116	12	potential	potential	ADJ
admet-207	116	13	unique	unique	ADJ
admet-207	116	14	biomarker	biomarker	NOUN
admet-207	116	15	predictive	predictive	NOUN
admet-207	116	16	of	of	ADP
admet-207	116	17	clinical	clinical	ADJ
admet-207	116	18	benefit	benefit	NOUN
admet-207	116	19	(	(	PUNCT
admet-207	116	20	i.e.	i.e.	X
admet-207	116	21	progression	progression	NOUN
admet-207	116	22	free	free	ADJ
admet-207	116	23	survival	survival	NOUN
admet-207	116	24	)	)	PUNCT
admet-207	116	25	of	of	ADP
admet-207	116	26	mcrc	mcrc	NOUN
admet-207	116	27	patients	patient	NOUN
admet-207	116	28	treated	treat	VERB
admet-207	116	29	with	with	ADP
admet-207	116	30	anti	anti	ADJ
admet-207	116	31	-	-	ADJ
admet-207	116	32	egfr	egfr	ADJ
admet-207	116	33	therapy	therapy	NOUN
admet-207	116	34	[	[	X
admet-207	116	35	41	41	NUM
admet-207	116	36	]	]	PUNCT
admet-207	116	37	.	.	PUNCT
admet-207	117	1	the	the	DET
admet-207	117	2	high	high	ADJ
admet-207	117	3	level	level	NOUN
admet-207	117	4	of	of	ADP
admet-207	117	5	telomerase	telomerase	NOUN
admet-207	117	6	activity	activity	NOUN
admet-207	117	7	may	may	AUX
admet-207	117	8	be	be	AUX
admet-207	117	9	an	an	DET
admet-207	117	10	independent	independent	ADJ
admet-207	117	11	prognosis	prognosis	NOUN
admet-207	117	12	-	-	PUNCT
admet-207	117	13	predicting	predict	VERB
admet-207	117	14	factor	factor	NOUN
admet-207	117	15	in	in	ADP
admet-207	117	16	the	the	DET
admet-207	117	17	patients	patient	NOUN
admet-207	117	18	with	with	ADP
admet-207	117	19	colorectal	colorectal	ADJ
admet-207	117	20	cancer	cancer	NOUN
admet-207	117	21	[	[	X
admet-207	117	22	42	42	NUM
admet-207	117	23	]	]	PUNCT
admet-207	117	24	.	.	PUNCT
admet-207	118	1	prospect	prospect	NOUN
admet-207	118	2	to	to	PART
admet-207	118	3	sum	sum	VERB
admet-207	118	4	up	up	ADP
admet-207	118	5	,	,	PUNCT
admet-207	118	6	the	the	DET
admet-207	118	7	related	related	ADJ
admet-207	118	8	research	research	NOUN
admet-207	118	9	shows	show	VERB
admet-207	118	10	that	that	SCONJ
admet-207	118	11	the	the	DET
admet-207	118	12	occurrence	occurrence	NOUN
admet-207	118	13	and	and	CCONJ
admet-207	118	14	changes	change	NOUN
admet-207	118	15	of	of	ADP
admet-207	118	16	degenerative	degenerative	ADJ
admet-207	118	17	diseases	disease	NOUN
admet-207	118	18	is	be	AUX
admet-207	118	19	closely	closely	ADV
admet-207	118	20	related	relate	VERB
admet-207	118	21	to	to	ADP
admet-207	118	22	telomere	telomere	NOUN
admet-207	118	23	shortening	shortening	NOUN
admet-207	118	24	.	.	PUNCT
admet-207	119	1	especially	especially	ADV
admet-207	119	2	,	,	PUNCT
admet-207	119	3	the	the	DET
admet-207	119	4	study	study	NOUN
admet-207	119	5	for	for	ADP
admet-207	119	6	patients	patient	NOUN
admet-207	119	7	with	with	ADP
admet-207	119	8	alzheimer	alzheimer	PROPN
admet-207	119	9	and	and	CCONJ
admet-207	119	10	parkinson	parkinson	NOUN
admet-207	119	11	shows	show	VERB
admet-207	119	12	that	that	SCONJ
admet-207	119	13	the	the	DET
admet-207	119	14	dysfunction	dysfunction	NOUN
admet-207	119	15	of	of	ADP
admet-207	119	16	telomerase	telomerase	NOUN
admet-207	119	17	activity	activity	NOUN
admet-207	119	18	and	and	CCONJ
admet-207	119	19	telomere	telomere	NOUN
admet-207	119	20	shortening	shortening	NOUN
admet-207	119	21	which	which	PRON
admet-207	119	22	may	may	AUX
admet-207	119	23	lead	lead	VERB
admet-207	119	24	to	to	ADP
admet-207	119	25	the	the	DET
admet-207	119	26	occurrence	occurrence	NOUN
admet-207	119	27	of	of	ADP
admet-207	119	28	these	these	DET
admet-207	119	29	disease	disease	NOUN
admet-207	119	30	and	and	CCONJ
admet-207	119	31	relate	relate	VERB
admet-207	119	32	to	to	ADP
admet-207	119	33	the	the	DET
admet-207	119	34	severity	severity	NOUN
admet-207	119	35	of	of	ADP
admet-207	119	36	the	the	DET
admet-207	119	37	disease	disease	NOUN
admet-207	119	38	.	.	PUNCT
admet-207	120	1	through	through	ADP
admet-207	120	2	the	the	DET
admet-207	120	3	study	study	NOUN
admet-207	120	4	of	of	ADP
admet-207	120	5	telomerase	telomerase	NOUN
admet-207	120	6	activity	activity	NOUN
admet-207	120	7	,	,	PUNCT
admet-207	120	8	it	it	PRON
admet-207	120	9	may	may	AUX
admet-207	120	10	be	be	AUX
admet-207	120	11	possible	possible	ADJ
admet-207	120	12	to	to	PART
admet-207	120	13	find	find	VERB
admet-207	120	14	new	new	ADJ
admet-207	120	15	ways	way	NOUN
admet-207	120	16	of	of	ADP
admet-207	120	17	treatment	treatment	NOUN
admet-207	120	18	for	for	ADP
admet-207	120	19	these	these	DET
admet-207	120	20	two	two	NUM
admet-207	120	21	diseases	disease	NOUN
admet-207	120	22	.	.	PUNCT
admet-207	121	1	in	in	ADP
admet-207	121	2	addition	addition	NOUN
admet-207	121	3	,	,	PUNCT
admet-207	121	4	there	there	PRON
admet-207	121	5	are	be	VERB
admet-207	121	6	studies	study	NOUN
admet-207	121	7	to	to	PART
admet-207	121	8	explore	explore	VERB
admet-207	121	9	the	the	DET
admet-207	121	10	relationships	relationship	NOUN
admet-207	121	11	and	and	CCONJ
admet-207	121	12	related	related	ADJ
admet-207	121	13	mechanisms	mechanism	NOUN
admet-207	121	14	between	between	ADP
admet-207	121	15	tumor	tumor	NOUN
admet-207	121	16	and	and	CCONJ
admet-207	121	17	telomere	telomere	NOUN
admet-207	121	18	,	,	PUNCT
admet-207	121	19	telomerase	telomerase	NOUN
admet-207	121	20	.	.	PUNCT
admet-207	122	1	telomerase	telomerase	NOUN
admet-207	122	2	activation	activation	NOUN
admet-207	122	3	and	and	CCONJ
admet-207	122	4	telomere	telomere	NOUN
admet-207	122	5	shortening	shortening	NOUN
admet-207	122	6	are	be	AUX
admet-207	122	7	closely	closely	ADV
admet-207	122	8	related	relate	VERB
admet-207	122	9	to	to	ADP
admet-207	122	10	the	the	DET
admet-207	122	11	occurrence	occurrence	NOUN
admet-207	122	12	and	and	CCONJ
admet-207	122	13	development	development	NOUN
admet-207	122	14	of	of	ADP
admet-207	122	15	malignant	malignant	ADJ
admet-207	122	16	tumor	tumor	NOUN
admet-207	122	17	.	.	PUNCT
admet-207	123	1	currently	currently	ADV
admet-207	123	2	,	,	PUNCT
admet-207	123	3	the	the	DET
admet-207	123	4	study	study	NOUN
admet-207	123	5	of	of	ADP
admet-207	123	6	telomerase	telomerase	NOUN
admet-207	123	7	targeted	target	VERB
admet-207	123	8	drugs	drug	NOUN
admet-207	123	9	for	for	ADP
admet-207	123	10	the	the	DET
admet-207	123	11	treatment	treatment	NOUN
admet-207	123	12	of	of	ADP
admet-207	123	13	cancer	cancer	NOUN
admet-207	123	14	has	have	AUX
admet-207	123	15	c.	c.	PROPN
admet-207	123	16	li	li	PROPN
admet-207	123	17	and	and	CCONJ
admet-207	123	18	y.	y.	PROPN
admet-207	123	19	gang	gang	PROPN
admet-207	123	20	admet	admet	PROPN
admet-207	123	21	&	&	CCONJ
admet-207	123	22	dmpk	dmpk	PROPN
admet-207	123	23	3(3	3(3	NUM
admet-207	123	24	)	)	PUNCT
admet-207	123	25	(	(	PUNCT
admet-207	123	26	2015	2015	NUM
admet-207	123	27	)	)	PUNCT
admet-207	123	28	254	254	NUM
admet-207	123	29	-	-	SYM
admet-207	123	30	259	259	NUM
admet-207	123	31	258	258	NUM
admet-207	123	32	entered	enter	VERB
admet-207	123	33	the	the	DET
admet-207	123	34	phase	phase	NOUN
admet-207	123	35	iii	iii	NUM
admet-207	123	36	clinical	clinical	ADJ
admet-207	123	37	trials	trial	NOUN
admet-207	123	38	.	.	PUNCT
admet-207	124	1	hopefully	hopefully	ADV
admet-207	124	2	findings	finding	VERB
admet-207	124	3	from	from	ADP
admet-207	124	4	these	these	DET
admet-207	124	5	studies	study	NOUN
admet-207	124	6	will	will	AUX
admet-207	124	7	emerge	emerge	VERB
admet-207	124	8	as	as	ADP
admet-207	124	9	a	a	DET
admet-207	124	10	new	new	ADJ
admet-207	124	11	approach	approach	NOUN
admet-207	124	12	for	for	ADP
admet-207	124	13	cancer	cancer	NOUN
admet-207	124	14	therapy	therapy	NOUN
admet-207	124	15	.	.	PUNCT
admet-207	125	1	references	reference	NOUN
admet-207	125	2	[	[	X
admet-207	125	3	1	1	X
admet-207	125	4	]	]	X
admet-207	125	5	r.k	r.k	PROPN
admet-207	125	6	.	.	PROPN
admet-207	125	7	moyzis	moyzi	NOUN
admet-207	125	8	,	,	PUNCT
admet-207	125	9	j.m	j.m	PROPN
admet-207	125	10	.	.	PROPN
admet-207	125	11	buckingham	buckingham	PROPN
admet-207	125	12	,	,	PUNCT
admet-207	125	13	l.s	l.s	PROPN
admet-207	125	14	.	.	PROPN
admet-207	125	15	cram	cram	PROPN
admet-207	125	16	,	,	PUNCT
admet-207	125	17	m.	m.	PROPN
admet-207	125	18	dani	dani	PROPN
admet-207	125	19	,	,	PUNCT
admet-207	125	20	l.l	l.l	PROPN
admet-207	125	21	.	.	PROPN
admet-207	125	22	deaven	deaven	PROPN
admet-207	125	23	,	,	PUNCT
admet-207	125	24	m.d	m.d	PROPN
admet-207	125	25	.	.	PROPN
admet-207	125	26	jones	jones	PROPN
admet-207	125	27	,	,	PUNCT
admet-207	125	28	j.	j.	PROPN
admet-207	125	29	meyne	meyne	PROPN
admet-207	125	30	,	,	PUNCT
admet-207	125	31	r.l	r.l	PROPN
admet-207	125	32	.	.	PROPN
admet-207	125	33	ratliff	ratliff	PROPN
admet-207	125	34	,	,	PUNCT
admet-207	125	35	j.r	j.r	PROPN
admet-207	125	36	.	.	PROPN
admet-207	125	37	wu	wu	PROPN
admet-207	125	38	,	,	PUNCT
admet-207	125	39	proc	proc	PROPN
admet-207	125	40	.	.	PUNCT
admet-207	126	1	natl	natl	PROPN
admet-207	126	2	.	.	PUNCT
admet-207	127	1	acad	acad	PROPN
admet-207	127	2	.	.	PUNCT
admet-207	128	1	sci	sci	PROPN
admet-207	128	2	.	.	PROPN
admet-207	128	3	usa	usa	PROPN
admet-207	128	4	85	85	NUM
admet-207	128	5	(	(	PUNCT
admet-207	128	6	1988	1988	NUM
admet-207	128	7	)	)	PUNCT
admet-207	128	8	6622	6622	NUM
admet-207	128	9	-	-	SYM
admet-207	128	10	6626	6626	NUM
admet-207	128	11	.	.	PUNCT
admet-207	129	1	[	[	X
admet-207	129	2	2	2	NUM
admet-207	129	3	]	]	X
admet-207	129	4	e.h	e.h	PROPN
admet-207	129	5	.	.	PROPN
admet-207	129	6	blackburn	blackburn	PROPN
admet-207	129	7	,	,	PUNCT
admet-207	129	8	nature	nature	NOUN
admet-207	129	9	350	350	NUM
admet-207	129	10	(	(	PUNCT
admet-207	129	11	1991	1991	NUM
admet-207	129	12	)	)	PUNCT
admet-207	129	13	569	569	NUM
admet-207	129	14	-	-	SYM
admet-207	129	15	573	573	NUM
admet-207	129	16	.	.	PUNCT
admet-207	130	1	[	[	X
admet-207	130	2	3	3	X
admet-207	130	3	]	]	X
admet-207	130	4	h.j	h.j	PROPN
admet-207	130	5	.	.	PROPN
admet-207	130	6	muller	muller	PROPN
admet-207	130	7	,	,	PUNCT
admet-207	130	8	the	the	DET
admet-207	130	9	collecting	collect	VERB
admet-207	130	10	net	net	ADJ
admet-207	130	11	13	13	NUM
admet-207	130	12	(	(	PUNCT
admet-207	130	13	1938	1938	NUM
admet-207	130	14	)	)	PUNCT
admet-207	130	15	181	181	NUM
admet-207	130	16	-	-	SYM
admet-207	130	17	198	198	NUM
admet-207	130	18	.	.	PUNCT
admet-207	131	1	[	[	X
admet-207	131	2	4	4	X
admet-207	131	3	]	]	X
admet-207	131	4	c.w	c.w	PROPN
admet-207	131	5	.	.	PROPN
admet-207	131	6	greider	greider	NOUN
admet-207	131	7	,	,	PUNCT
admet-207	131	8	e.h	e.h	PROPN
admet-207	131	9	.	.	PROPN
admet-207	131	10	blackburn	blackburn	PROPN
admet-207	131	11	,	,	PUNCT
admet-207	131	12	cell	cell	NOUN
admet-207	131	13	43(2pt1	43(2pt1	NOUN
admet-207	131	14	)	)	PUNCT
admet-207	131	15	(	(	PUNCT
admet-207	131	16	1985	1985	NUM
admet-207	131	17	)	)	PUNCT
admet-207	131	18	405	405	NUM
admet-207	131	19	-	-	SYM
admet-207	131	20	413	413	NUM
admet-207	131	21	.	.	PUNCT
admet-207	132	1	[	[	X
admet-207	132	2	5	5	NUM
admet-207	132	3	]	]	X
admet-207	132	4	m.g	m.g	PROPN
admet-207	132	5	.	.	PROPN
admet-207	132	6	ferreira	ferreira	PROPN
admet-207	132	7	,	,	PUNCT
admet-207	132	8	k.m	k.m	PROPN
admet-207	132	9	.	.	PROPN
admet-207	132	10	miller	miller	PROPN
admet-207	132	11	,	,	PUNCT
admet-207	132	12	j.p	j.p	PROPN
admet-207	132	13	.	.	PROPN
admet-207	132	14	cooper	cooper	PROPN
admet-207	132	15	,	,	PUNCT
admet-207	132	16	mol	mol	PROPN
admet-207	132	17	.	.	PROPN
admet-207	132	18	cell	cell	NOUN
admet-207	132	19	.	.	PUNCT
admet-207	133	1	13	13	NUM
admet-207	133	2	(	(	PUNCT
admet-207	133	3	2004	2004	NUM
admet-207	133	4	)	)	PUNCT
admet-207	133	5	7	7	NUM
admet-207	133	6	-	-	SYM
admet-207	133	7	18	18	NUM
admet-207	133	8	.	.	PUNCT
admet-207	134	1	[	[	X
admet-207	134	2	6	6	NUM
admet-207	134	3	]	]	X
admet-207	134	4	d.	d.	PROPN
admet-207	134	5	li	li	PROPN
admet-207	134	6	,	,	PUNCT
admet-207	134	7	q.	q.	PROPN
admet-207	134	8	yuan	yuan	PROPN
admet-207	134	9	,	,	PUNCT
admet-207	134	10	w.	w.	PROPN
admet-207	134	11	wang	wang	PROPN
admet-207	134	12	,	,	PUNCT
admet-207	134	13	j.	j.	PROPN
admet-207	134	14	int	int	PROPN
admet-207	134	15	.	.	PUNCT
admet-207	135	1	med	med	PROPN
admet-207	135	2	.	.	PUNCT
admet-207	136	1	res	re	NOUN
admet-207	136	2	.	.	PROPN
admet-207	137	1	40	40	NUM
admet-207	137	2	(	(	PUNCT
admet-207	137	3	2012	2012	NUM
admet-207	137	4	)	)	PUNCT
admet-207	137	5	1242	1242	NUM
admet-207	137	6	-	-	SYM
admet-207	137	7	1250	1250	NUM
admet-207	137	8	.	.	PUNCT
admet-207	138	1	[	[	X
admet-207	138	2	7	7	X
admet-207	138	3	]	]	X
admet-207	138	4	d.	d.	PROPN
admet-207	138	5	liu	liu	PROPN
admet-207	138	6	,	,	PUNCT
admet-207	138	7	m.s	m.s	PROPN
admet-207	138	8	.	.	PROPN
admet-207	138	9	o’connor	o’connor	PROPN
admet-207	138	10	,	,	PUNCT
admet-207	138	11	j.	j.	PROPN
admet-207	138	12	qin	qin	PROPN
admet-207	138	13	,	,	PUNCT
admet-207	138	14	z.	z.	PROPN
admet-207	138	15	songyang	songyang	PROPN
admet-207	138	16	,	,	PUNCT
admet-207	138	17	j.	j.	PROPN
admet-207	138	18	biol	biol	PROPN
admet-207	138	19	.	.	PUNCT
admet-207	139	1	chem	chem	NOUN
admet-207	139	2	.	.	PUNCT
admet-207	140	1	279	279	NUM
admet-207	140	2	(	(	PUNCT
admet-207	140	3	2004	2004	NUM
admet-207	140	4	)	)	PUNCT
admet-207	140	5	51338	51338	NUM
admet-207	140	6	-	-	SYM
admet-207	140	7	51342	51342	NUM
admet-207	140	8	.	.	PUNCT
admet-207	141	1	[	[	X
admet-207	141	2	8	8	NUM
admet-207	141	3	]	]	PUNCT
admet-207	141	4	t.	t.	PROPN
admet-207	141	5	de	de	X
admet-207	141	6	lange	lange	PROPN
admet-207	141	7	,	,	PUNCT
admet-207	141	8	genes	gene	NOUN
admet-207	141	9	dev	dev	PROPN
admet-207	141	10	.	.	PROPN
admet-207	141	11	19	19	NUM
admet-207	141	12	(	(	PUNCT
admet-207	141	13	2005	2005	NUM
admet-207	141	14	)	)	PUNCT
admet-207	141	15	2100	2100	NUM
admet-207	141	16	-	-	SYM
admet-207	141	17	2110	2110	NUM
admet-207	141	18	.	.	PUNCT
admet-207	142	1	[	[	X
admet-207	142	2	9	9	NUM
admet-207	142	3	]	]	X
admet-207	142	4	u.	u.	PROPN
admet-207	142	5	herbig	herbig	PROPN
admet-207	142	6	,	,	PUNCT
admet-207	142	7	w.a	w.a	PROPN
admet-207	142	8	.	.	PROPN
admet-207	142	9	jobling	jobling	PROPN
admet-207	142	10	,	,	PUNCT
admet-207	142	11	b.p	b.p	PROPN
admet-207	142	12	.	.	PROPN
admet-207	142	13	chen	chen	PROPN
admet-207	142	14	,	,	PUNCT
admet-207	142	15	d.j	d.j	PROPN
admet-207	142	16	.	.	PROPN
admet-207	142	17	chen	chen	PROPN
admet-207	142	18	,	,	PUNCT
admet-207	142	19	j.m	j.m	PROPN
admet-207	142	20	.	.	PROPN
admet-207	142	21	sedivy	sedivy	PROPN
admet-207	142	22	.	.	PUNCT
admet-207	143	1	mol	mol	PROPN
admet-207	143	2	.	.	PROPN
admet-207	143	3	cell	cell	NOUN
admet-207	143	4	14	14	NUM
admet-207	143	5	(	(	PUNCT
admet-207	143	6	2004	2004	NUM
admet-207	143	7	)	)	PUNCT
admet-207	143	8	501	501	NUM
admet-207	143	9	-	-	SYM
admet-207	143	10	513	513	NUM
admet-207	143	11	.	.	PUNCT
admet-207	144	1	[	[	X
admet-207	144	2	10	10	NUM
admet-207	144	3	]	]	X
admet-207	144	4	j.d	j.d	PROPN
admet-207	144	5	.	.	PROPN
admet-207	144	6	watson	watson	PROPN
admet-207	144	7	,	,	PUNCT
admet-207	144	8	nat	nat	PROPN
admet-207	144	9	.	.	PUNCT
admet-207	145	1	new	new	ADJ
admet-207	145	2	biol	biol	NOUN
admet-207	145	3	.	.	PUNCT
admet-207	146	1	239	239	NUM
admet-207	146	2	(	(	PUNCT
admet-207	146	3	1972	1972	NUM
admet-207	146	4	)	)	PUNCT
admet-207	146	5	197	197	NUM
admet-207	146	6	-	-	SYM
admet-207	146	7	201	201	NUM
admet-207	146	8	.	.	PUNCT
admet-207	147	1	[	[	X
admet-207	147	2	11	11	NUM
admet-207	147	3	]	]	X
admet-207	147	4	w.e	w.e	PROPN
admet-207	147	5	.	.	PROPN
admet-207	147	6	wright	wright	PROPN
admet-207	147	7	,	,	PUNCT
admet-207	147	8	m.a	m.a	PROPN
admet-207	147	9	.	.	PROPN
admet-207	147	10	piatyszek	piatyszek	PROPN
admet-207	147	11	,	,	PUNCT
admet-207	147	12	w.e	w.e	PROPN
admet-207	147	13	.	.	PROPN
admet-207	147	14	rainey	rainey	PROPN
admet-207	147	15	,	,	PUNCT
admet-207	147	16	w.	w.	PROPN
admet-207	147	17	byrd	byrd	PROPN
admet-207	147	18	,	,	PUNCT
admet-207	147	19	j.w	j.w	PROPN
admet-207	147	20	.	.	PROPN
admet-207	147	21	shay	shay	PROPN
admet-207	147	22	,	,	PUNCT
admet-207	147	23	dev	dev	PROPN
admet-207	147	24	.	.	PUNCT
admet-207	147	25	genet	genet	PROPN
admet-207	147	26	.	.	PUNCT
admet-207	148	1	18	18	NUM
admet-207	148	2	(	(	PUNCT
admet-207	148	3	1996	1996	NUM
admet-207	148	4	)	)	PUNCT
admet-207	148	5	173	173	NUM
admet-207	148	6	-	-	SYM
admet-207	148	7	179	179	NUM
admet-207	148	8	.	.	PUNCT
admet-207	149	1	[	[	X
admet-207	149	2	12	12	NUM
admet-207	149	3	]	]	X
admet-207	149	4	c.w	c.w	PROPN
admet-207	149	5	.	.	PROPN
admet-207	149	6	greider	greider	NOUN
admet-207	149	7	,	,	PUNCT
admet-207	149	8	e.h	e.h	PROPN
admet-207	149	9	.	.	PROPN
admet-207	149	10	blackburn	blackburn	PROPN
admet-207	149	11	,	,	PUNCT
admet-207	149	12	cell	cell	NOUN
admet-207	149	13	43	43	NUM
admet-207	149	14	(	(	PUNCT
admet-207	149	15	1985	1985	NUM
admet-207	149	16	)	)	PUNCT
admet-207	149	17	405	405	NUM
admet-207	149	18	-	-	SYM
admet-207	149	19	413	413	NUM
admet-207	149	20	.	.	PUNCT
admet-207	150	1	[	[	X
admet-207	150	2	13	13	NUM
admet-207	150	3	]	]	X
admet-207	150	4	c.	c.	PROPN
admet-207	150	5	autexier	autexier	PROPN
admet-207	150	6	,	,	PUNCT
admet-207	150	7	n.f	n.f	PROPN
admet-207	150	8	.	.	PROPN
admet-207	150	9	lue	lue	PROPN
admet-207	150	10	,	,	PUNCT
admet-207	150	11	annu	annu	PROPN
admet-207	150	12	.	.	PUNCT
admet-207	150	13	rev	rev	PROPN
admet-207	150	14	.	.	PROPN
admet-207	150	15	biochem	biochem	PROPN
admet-207	150	16	.	.	PUNCT
admet-207	151	1	75	75	NUM
admet-207	151	2	(	(	PUNCT
admet-207	151	3	2006	2006	NUM
admet-207	151	4	)	)	PUNCT
admet-207	151	5	493	493	NUM
admet-207	151	6	517	517	NUM
admet-207	151	7	.	.	PUNCT
admet-207	152	1	[	[	X
admet-207	152	2	14	14	NUM
admet-207	152	3	]	]	PUNCT
admet-207	152	4	q.	q.	PROPN
admet-207	152	5	zhang	zhang	PROPN
admet-207	152	6	,	,	PUNCT
admet-207	152	7	n.k	n.k	PROPN
admet-207	152	8	.	.	PROPN
admet-207	152	9	kim	kim	PROPN
admet-207	152	10	,	,	PUNCT
admet-207	152	11	j.	j.	PROPN
admet-207	152	12	feigon	feigon	PROPN
admet-207	152	13	,	,	PUNCT
admet-207	152	14	proc	proc	NOUN
admet-207	152	15	.	.	PUNCT
admet-207	152	16	natl	natl	PROPN
admet-207	152	17	.	.	PUNCT
admet-207	153	1	acad	acad	PROPN
admet-207	153	2	.	.	PUNCT
admet-207	154	1	sci	sci	PROPN
admet-207	154	2	.	.	PROPN
admet-207	154	3	usa	usa	PROPN
admet-207	154	4	108	108	NUM
admet-207	154	5	(	(	PUNCT
admet-207	154	6	2011	2011	NUM
admet-207	154	7	)	)	PUNCT
admet-207	154	8	20325	20325	NUM
admet-207	154	9	-	-	SYM
admet-207	154	10	20332	20332	NUM
admet-207	154	11	.	.	PUNCT
admet-207	155	1	[	[	X
admet-207	155	2	15	15	NUM
admet-207	155	3	]	]	X
admet-207	155	4	j.	j.	PROPN
admet-207	155	5	feng	feng	PROPN
admet-207	155	6	,	,	PUNCT
admet-207	155	7	w.d	w.d	PROPN
admet-207	155	8	.	.	PROPN
admet-207	155	9	funk	funk	PROPN
admet-207	155	10	,	,	PUNCT
admet-207	155	11	s.s	s.s	PROPN
admet-207	155	12	.	.	PROPN
admet-207	155	13	wang	wang	PROPN
admet-207	155	14	,	,	PUNCT
admet-207	155	15	s.l	s.l	PROPN
admet-207	155	16	.	.	PROPN
admet-207	155	17	weinrich	weinrich	PROPN
admet-207	155	18	,	,	PUNCT
admet-207	155	19	a.a	a.a	PROPN
admet-207	155	20	.	.	PROPN
admet-207	155	21	avilion	avilion	PROPN
admet-207	155	22	,	,	PUNCT
admet-207	155	23	c.p	c.p	PROPN
admet-207	155	24	.	.	PROPN
admet-207	155	25	chiu	chiu	PROPN
admet-207	155	26	,	,	PUNCT
admet-207	155	27	r.r	r.r	PROPN
admet-207	155	28	.	.	PROPN
admet-207	155	29	adams	adams	PROPN
admet-207	155	30	,	,	PUNCT
admet-207	155	31	e.	e.	PROPN
admet-207	155	32	chang	chang	PROPN
admet-207	155	33	,	,	PUNCT
admet-207	155	34	r.c	r.c	PROPN
admet-207	155	35	.	.	PROPN
admet-207	155	36	allsopp	allsopp	PROPN
admet-207	155	37	,	,	PUNCT
admet-207	155	38	j.	j.	PROPN
admet-207	155	39	yu	yu	PROPN
admet-207	155	40	,	,	PUNCT
admet-207	155	41	et	et	PROPN
admet-207	155	42	al	al	PROPN
admet-207	155	43	.	.	PROPN
admet-207	155	44	,	,	PUNCT
admet-207	155	45	science	science	NOUN
admet-207	155	46	269	269	NUM
admet-207	155	47	(	(	PUNCT
admet-207	155	48	1995	1995	NUM
admet-207	155	49	)	)	PUNCT
admet-207	155	50	1236	1236	NUM
admet-207	155	51	-	-	SYM
admet-207	155	52	1241	1241	NUM
admet-207	155	53	.	.	PUNCT
admet-207	156	1	[	[	X
admet-207	156	2	16	16	NUM
admet-207	156	3	]	]	PUNCT
admet-207	156	4	k.	k.	PROPN
admet-207	156	5	collins	collins	PROPN
admet-207	156	6	,	,	PUNCT
admet-207	156	7	j.r	j.r	PROPN
admet-207	156	8	.	.	PROPN
admet-207	156	9	mitchell	mitchell	PROPN
admet-207	156	10	,	,	PUNCT
admet-207	156	11	oncogene	oncogene	NOUN
admet-207	156	12	21	21	NUM
admet-207	156	13	(	(	PUNCT
admet-207	156	14	2002	2002	NUM
admet-207	156	15	)	)	PUNCT
admet-207	156	16	564	564	NUM
admet-207	156	17	-	-	SYM
admet-207	156	18	579	579	NUM
admet-207	156	19	.	.	PUNCT
admet-207	157	1	[	[	X
admet-207	157	2	17	17	NUM
admet-207	157	3	]	]	X
admet-207	157	4	l.a	l.a	PROPN
admet-207	157	5	.	.	PROPN
admet-207	157	6	panossian	panossian	PROPN
admet-207	157	7	,	,	PUNCT
admet-207	157	8	v.r	v.r	PROPN
admet-207	157	9	.	.	PROPN
admet-207	157	10	porter	porter	PROPN
admet-207	157	11	,	,	PUNCT
admet-207	157	12	h.f	h.f	PROPN
admet-207	157	13	.	.	PROPN
admet-207	157	14	valenzuela	valenzuela	PROPN
admet-207	157	15	,	,	PUNCT
admet-207	157	16	x.	x.	PROPN
admet-207	157	17	zhu	zhu	PROPN
admet-207	157	18	,	,	PUNCT
admet-207	157	19	e.	e.	PROPN
admet-207	157	20	reback	reback	PROPN
admet-207	157	21	,	,	PUNCT
admet-207	157	22	d.	d.	PROPN
admet-207	157	23	masterman	masterman	PROPN
admet-207	157	24	,	,	PUNCT
admet-207	157	25	j.l	j.l	PROPN
admet-207	157	26	.	.	PROPN
admet-207	157	27	cummings	cummings	PROPN
admet-207	157	28	,	,	PUNCT
admet-207	157	29	r.b	r.b	PROPN
admet-207	157	30	.	.	PROPN
admet-207	157	31	effros	effros	PROPN
admet-207	157	32	,	,	PUNCT
admet-207	157	33	neurobiol	neurobiol	PROPN
admet-207	157	34	.	.	PUNCT
admet-207	158	1	aging	age	VERB
admet-207	158	2	.	.	PUNCT
admet-207	159	1	24	24	NUM
admet-207	159	2	(	(	PUNCT
admet-207	159	3	2003	2003	NUM
admet-207	159	4	)	)	PUNCT
admet-207	159	5	77	77	NUM
admet-207	159	6	-	-	SYM
admet-207	159	7	84	84	NUM
admet-207	159	8	.	.	PUNCT
admet-207	160	1	[	[	X
admet-207	160	2	18	18	NUM
admet-207	160	3	]	]	X
admet-207	160	4	e.c	e.c	PROPN
admet-207	160	5	.	.	PROPN
admet-207	160	6	jenkins	jenkins	PROPN
admet-207	160	7	,	,	PUNCT
admet-207	160	8	m.t	m.t	PROPN
admet-207	160	9	.	.	PROPN
admet-207	160	10	velinov	velinov	PROPN
admet-207	160	11	,	,	PUNCT
admet-207	160	12	l.	l.	PROPN
admet-207	160	13	ye	ye	PROPN
admet-207	160	14	,	,	PUNCT
admet-207	160	15	h.	h.	PROPN
admet-207	160	16	gu	gu	PROPN
admet-207	160	17	,	,	PUNCT
admet-207	160	18	s.	s.	PROPN
admet-207	160	19	li	li	PROPN
admet-207	160	20	,	,	PUNCT
admet-207	160	21	e.c	e.c	PROPN
admet-207	160	22	.	.	PROPN
admet-207	160	23	jenkins	jenkins	PROPN
admet-207	160	24	jr	jr	PROPN
admet-207	160	25	,	,	PUNCT
admet-207	160	26	s.s	s.s	PROPN
admet-207	160	27	.	.	PROPN
admet-207	160	28	brooks	brooks	PROPN
admet-207	160	29	,	,	PUNCT
admet-207	160	30	d.	d.	PROPN
admet-207	160	31	pang	pang	PROPN
admet-207	160	32	,	,	PUNCT
admet-207	160	33	d.a	d.a	PROPN
admet-207	160	34	.	.	PROPN
admet-207	160	35	devenny	devenny	PROPN
admet-207	160	36	,	,	PUNCT
admet-207	160	37	w.b	w.b	PROPN
admet-207	160	38	.	.	PROPN
admet-207	160	39	zigman	zigman	PROPN
admet-207	160	40	,	,	PUNCT
admet-207	160	41	n.	n.	PROPN
admet-207	160	42	schupf	schupf	PROPN
admet-207	160	43	,	,	PUNCT
admet-207	160	44	w.p	w.p	PROPN
admet-207	160	45	.	.	PROPN
admet-207	160	46	silverman	silverman	PROPN
admet-207	160	47	,	,	PUNCT
admet-207	160	48	neurobiol	neurobiol	PROPN
admet-207	160	49	.	.	PUNCT
admet-207	161	1	aging	age	VERB
admet-207	161	2	.	.	PUNCT
admet-207	162	1	27	27	NUM
admet-207	162	2	(	(	PUNCT
admet-207	162	3	2006	2006	NUM
admet-207	162	4	)	)	PUNCT
admet-207	162	5	941	941	NUM
admet-207	162	6	-	-	SYM
admet-207	162	7	945	945	NUM
admet-207	162	8	.	.	PUNCT
admet-207	163	1	[	[	X
admet-207	163	2	19	19	NUM
admet-207	163	3	]	]	X
admet-207	163	4	l.s	l.s	PROPN
admet-207	163	5	.	.	PROPN
admet-207	163	6	honig	honig	PROPN
admet-207	163	7	,	,	PUNCT
admet-207	163	8	n.	n.	PROPN
admet-207	163	9	schupf	schupf	PROPN
admet-207	163	10	,	,	PUNCT
admet-207	163	11	j.h	j.h	PROPN
admet-207	163	12	.	.	PROPN
admet-207	163	13	lee	lee	PROPN
admet-207	163	14	,	,	PUNCT
admet-207	163	15	m.x	m.x	PROPN
admet-207	163	16	.	.	PROPN
admet-207	163	17	tang	tang	PROPN
admet-207	163	18	,	,	PUNCT
admet-207	163	19	r.	r.	PROPN
admet-207	163	20	mayeux	mayeux	PROPN
admet-207	163	21	,	,	PUNCT
admet-207	163	22	ann	ann	PROPN
admet-207	163	23	.	.	PUNCT
admet-207	164	1	neurol	neurol	PROPN
admet-207	164	2	.	.	PUNCT
admet-207	165	1	60	60	NUM
admet-207	165	2	(	(	PUNCT
admet-207	165	3	2006	2006	NUM
admet-207	165	4	)	)	PUNCT
admet-207	165	5	181	181	NUM
admet-207	165	6	-	-	SYM
admet-207	165	7	187	187	NUM
admet-207	165	8	.	.	PUNCT
admet-207	166	1	[	[	X
admet-207	166	2	20	20	NUM
admet-207	166	3	]	]	PUNCT
admet-207	166	4	p.	p.	NOUN
admet-207	166	5	thomas	thomas	PROPN
admet-207	166	6	,	,	PUNCT
admet-207	166	7	n.j	n.j	PROPN
admet-207	166	8	.	.	PROPN
admet-207	166	9	o'callaghan	o'callaghan	PROPN
admet-207	166	10	,	,	PUNCT
admet-207	166	11	m.	m.	NOUN
admet-207	166	12	fenech	fenech	PROPN
admet-207	166	13	,	,	PUNCT
admet-207	166	14	mech	mech	NOUN
admet-207	166	15	.	.	PUNCT
admet-207	166	16	ageing	age	VERB
admet-207	166	17	dev	dev	PROPN
admet-207	166	18	.	.	PROPN
admet-207	167	1	129	129	NUM
admet-207	167	2	(	(	PUNCT
admet-207	167	3	2008)183	2008)183	NUM
admet-207	167	4	-	-	SYM
admet-207	167	5	190	190	NUM
admet-207	167	6	.	.	PUNCT
admet-207	168	1	[	[	X
admet-207	168	2	21	21	NUM
admet-207	168	3	]	]	PUNCT
admet-207	168	4	j.	j.	PROPN
admet-207	168	5	nicholas	nicholas	PROPN
admet-207	168	6	lukens	lukens	PROPN
admet-207	168	7	,	,	PUNCT
admet-207	168	8	v.	v.	PROPN
admet-207	168	9	van	van	PROPN
admet-207	168	10	deerlin	deerlin	PROPN
admet-207	168	11	,	,	PUNCT
admet-207	168	12	c.m	c.m	PROPN
admet-207	168	13	.	.	PROPN
admet-207	168	14	clark	clark	PROPN
admet-207	168	15	,	,	PUNCT
admet-207	168	16	s.x	s.x	PROPN
admet-207	168	17	.	.	PUNCT
admet-207	168	18	xie	xie	PROPN
admet-207	168	19	,	,	PUNCT
admet-207	168	20	f.b	f.b	PROPN
admet-207	168	21	.	.	PROPN
admet-207	168	22	johnson	johnson	PROPN
admet-207	168	23	,	,	PUNCT
admet-207	168	24	alzheimers	alzheimers	PROPN
admet-207	168	25	dement	dement	PROPN
admet-207	168	26	.	.	PUNCT
admet-207	169	1	5(6	5(6	NUM
admet-207	169	2	)	)	PUNCT
admet-207	169	3	(	(	PUNCT
admet-207	169	4	2009	2009	NUM
admet-207	169	5	)	)	PUNCT
admet-207	169	6	463	463	NUM
admet-207	169	7	-	-	SYM
admet-207	169	8	469	469	NUM
admet-207	169	9	.	.	PUNCT
admet-207	170	1	[	[	X
admet-207	170	2	22	22	NUM
admet-207	170	3	]	]	PUNCT
admet-207	170	4	h.	h.	PROPN
admet-207	170	5	wang	wang	PROPN
admet-207	170	6	,	,	PUNCT
admet-207	170	7	h.	h.	PROPN
admet-207	170	8	chen	chen	PROPN
admet-207	170	9	,	,	PUNCT
admet-207	170	10	x.	x.	PROPN
admet-207	170	11	gao	gao	PROPN
admet-207	170	12	,	,	PUNCT
admet-207	170	13	m.	m.	PROPN
admet-207	170	14	mcgrath	mcgrath	PROPN
admet-207	170	15	,	,	PUNCT
admet-207	170	16	d.	d.	PROPN
admet-207	170	17	deer	deer	PROPN
admet-207	170	18	,	,	PUNCT
admet-207	170	19	i.	i.	PROPN
admet-207	170	20	de	de	X
admet-207	170	21	vivo	vivo	PROPN
admet-207	170	22	,	,	PUNCT
admet-207	170	23	m.a	m.a	PROPN
admet-207	170	24	.	.	PROPN
admet-207	170	25	schwarzschild	schwarzschild	PROPN
admet-207	170	26	,	,	PUNCT
admet-207	170	27	a.	a.	NOUN
admet-207	170	28	ascherio	ascherio	NOUN
admet-207	170	29	,	,	PUNCT
admet-207	170	30	mov	mov	NOUN
admet-207	170	31	.	.	PUNCT
admet-207	170	32	disord	disord	PROPN
admet-207	170	33	.	.	PUNCT
admet-207	171	1	23	23	NUM
admet-207	171	2	(	(	PUNCT
admet-207	171	3	2008	2008	NUM
admet-207	171	4	)	)	PUNCT
admet-207	171	5	302	302	NUM
admet-207	171	6	-	-	SYM
admet-207	171	7	305	305	NUM
admet-207	171	8	.	.	PUNCT
admet-207	172	1	[	[	X
admet-207	172	2	23	23	NUM
admet-207	172	3	]	]	X
admet-207	172	4	j.z	j.z	PROPN
admet-207	172	5	.	.	PROPN
admet-207	172	6	guan	guan	PROPN
admet-207	172	7	,	,	PUNCT
admet-207	172	8	t.	t.	PROPN
admet-207	172	9	maeda	maeda	PROPN
admet-207	172	10	,	,	PUNCT
admet-207	172	11	m.	m.	NOUN
admet-207	172	12	sugano	sugano	PROPN
admet-207	172	13	,	,	PUNCT
admet-207	172	14	j.	j.	PROPN
admet-207	172	15	oyama	oyama	PROPN
admet-207	172	16	,	,	PUNCT
admet-207	172	17	y.	y.	PROPN
admet-207	172	18	higuchi	higuchi	PROPN
admet-207	172	19	,	,	PUNCT
admet-207	172	20	t.	t.	PROPN
admet-207	172	21	suzuki	suzuki	PROPN
admet-207	172	22	,	,	PUNCT
admet-207	172	23	n.	n.	PROPN
admet-207	172	24	makino	makino	PROPN
admet-207	172	25	,	,	PUNCT
admet-207	172	26	j.	j.	PROPN
admet-207	172	27	gerontol	gerontol	PROPN
admet-207	172	28	.	.	PUNCT
admet-207	173	1	a	a	DET
admet-207	173	2	biol	biol	NOUN
admet-207	173	3	.	.	PUNCT
admet-207	174	1	sci	sci	PROPN
admet-207	174	2	.	.	PROPN
admet-207	174	3	med	med	PROPN
admet-207	174	4	.	.	PUNCT
admet-207	175	1	sci	sci	PROPN
admet-207	175	2	.	.	PROPN
admet-207	176	1	63	63	NUM
admet-207	176	2	(	(	PUNCT
admet-207	176	3	2008	2008	NUM
admet-207	176	4	)	)	PUNCT
admet-207	176	5	467	467	NUM
admet-207	176	6	-	-	SYM
admet-207	176	7	473	473	NUM
admet-207	176	8	.	.	PUNCT
admet-207	177	1	[	[	X
admet-207	177	2	24	24	NUM
admet-207	177	3	]	]	PUNCT
admet-207	177	4	t.	t.	PROPN
admet-207	177	5	maeda	maeda	PROPN
admet-207	177	6	,	,	PUNCT
admet-207	177	7	j.z	j.z	PROPN
admet-207	177	8	.	.	PROPN
admet-207	177	9	guan	guan	PROPN
admet-207	177	10	,	,	PUNCT
admet-207	177	11	j.	j.	PROPN
admet-207	177	12	oyama	oyama	PROPN
admet-207	177	13	,	,	PUNCT
admet-207	177	14	y.	y.	PROPN
admet-207	177	15	higuchi	higuchi	PROPN
admet-207	177	16	,	,	PUNCT
admet-207	177	17	n.	n.	PROPN
admet-207	177	18	makino	makino	PROPN
admet-207	177	19	,	,	PUNCT
admet-207	177	20	j.	j.	PROPN
admet-207	177	21	gerontol	gerontol	PROPN
admet-207	177	22	.	.	PUNCT
admet-207	178	1	a	a	DET
admet-207	178	2	biol	biol	NOUN
admet-207	178	3	.	.	PUNCT
admet-207	179	1	sci	sci	PROPN
admet-207	179	2	.	.	PROPN
admet-207	179	3	med	med	PROPN
admet-207	179	4	.	.	PUNCT
admet-207	180	1	sci	sci	PROPN
admet-207	180	2	.	.	PROPN
admet-207	181	1	64	64	NUM
admet-207	181	2	(	(	PUNCT
admet-207	181	3	2009	2009	NUM
admet-207	181	4	)	)	PUNCT
admet-207	181	5	949955	949955	NUM
admet-207	181	6	.	.	PUNCT
admet-207	182	1	[	[	X
admet-207	182	2	25	25	NUM
admet-207	182	3	]	]	X
admet-207	182	4	g.	g.	PROPN
admet-207	182	5	hudson	hudson	PROPN
admet-207	182	6	,	,	PUNCT
admet-207	182	7	d.	d.	PROPN
admet-207	182	8	faini	faini	PROPN
admet-207	182	9	,	,	PUNCT
admet-207	182	10	a.	a.	NOUN
admet-207	182	11	stutt	stutt	PROPN
admet-207	182	12	,	,	PUNCT
admet-207	182	13	m.	m.	NOUN
admet-207	182	14	eccles	eccles	PROPN
admet-207	182	15	,	,	PUNCT
admet-207	182	16	l.	l.	PROPN
admet-207	182	17	robinson	robinson	PROPN
admet-207	182	18	,	,	PUNCT
admet-207	182	19	d.j	d.j	PROPN
admet-207	182	20	.	.	PROPN
admet-207	182	21	burn	burn	PROPN
admet-207	182	22	,	,	PUNCT
admet-207	182	23	p.f	p.f	PROPN
admet-207	182	24	.	.	PROPN
admet-207	182	25	chinnery	chinnery	PROPN
admet-207	182	26	,	,	PUNCT
admet-207	182	27	neurobiol	neurobiol	NOUN
admet-207	182	28	aging	aging	NOUN
admet-207	182	29	.	.	PUNCT
admet-207	183	1	32(11	32(11	NUM
admet-207	183	2	)	)	PUNCT
admet-207	183	3	(	(	PUNCT
admet-207	183	4	2011	2011	NUM
admet-207	183	5	)	)	PUNCT
admet-207	183	6	2107.e3	2107.e3	NOUN
admet-207	183	7	-	-	SYM
admet-207	183	8	2107.5	2107.5	NUM
admet-207	183	9	.	.	PUNCT
admet-207	184	1	[	[	X
admet-207	184	2	26	26	NUM
admet-207	184	3	]	]	PUNCT
admet-207	184	4	j.	j.	PROPN
admet-207	184	5	eerola	eerola	PROPN
admet-207	184	6	,	,	PUNCT
admet-207	184	7	l.	l.	PROPN
admet-207	184	8	kananen	kananen	PROPN
admet-207	184	9	,	,	PUNCT
admet-207	184	10	k.	k.	PROPN
admet-207	184	11	manninen	manninen	PROPN
admet-207	184	12	,	,	PUNCT
admet-207	184	13	o.	o.	PROPN
admet-207	184	14	hellström	hellström	PROPN
admet-207	184	15	,	,	PUNCT
admet-207	184	16	p.j	p.j	PROPN
admet-207	184	17	.	.	PROPN
admet-207	184	18	tienari	tienari	PROPN
admet-207	184	19	,	,	PUNCT
admet-207	184	20	i.	i.	NOUN
admet-207	184	21	hovatta	hovatta	PROPN
admet-207	184	22	,	,	PUNCT
admet-207	184	23	j.	j.	PROPN
admet-207	184	24	gerontol	gerontol	PROPN
admet-207	184	25	.	.	PUNCT
admet-207	185	1	a	a	DET
admet-207	185	2	biol	biol	NOUN
admet-207	185	3	.	.	PUNCT
admet-207	186	1	sci	sci	PROPN
admet-207	186	2	.	.	PROPN
admet-207	186	3	med	med	PROPN
admet-207	186	4	.	.	PUNCT
admet-207	187	1	sci	sci	PROPN
admet-207	187	2	.	.	PUNCT
admet-207	188	1	65(11	65(11	NUM
admet-207	188	2	)	)	PUNCT
admet-207	188	3	(	(	PUNCT
admet-207	188	4	2010	2010	NUM
admet-207	188	5	)	)	PUNCT
admet-207	188	6	1181	1181	NUM
admet-207	188	7	-	-	SYM
admet-207	188	8	1184	1184	NUM
admet-207	188	9	.	.	PUNCT
admet-207	189	1	[	[	X
admet-207	189	2	27	27	NUM
admet-207	189	3	]	]	X
admet-207	189	4	c.	c.	PROPN
admet-207	189	5	zhang	zhang	PROPN
admet-207	189	6	,	,	PUNCT
admet-207	189	7	x.	x.	PROPN
admet-207	189	8	chen	chen	PROPN
admet-207	189	9	,	,	PUNCT
admet-207	189	10	l.	l.	PROPN
admet-207	189	11	li	li	PROPN
admet-207	189	12	,	,	PUNCT
admet-207	189	13	y.	y.	PROPN
admet-207	189	14	zhou	zhou	PROPN
admet-207	189	15	,	,	PUNCT
admet-207	189	16	c.	c.	PROPN
admet-207	189	17	wang	wang	PROPN
admet-207	189	18	,	,	PUNCT
admet-207	189	19	s.	s.	PROPN
admet-207	189	20	hou	hou	PROPN
admet-207	189	21	,	,	PUNCT
admet-207	189	22	plos	plos	PROPN
admet-207	189	23	one	one	NUM
admet-207	189	24	(	(	PUNCT
admet-207	189	25	2015	2015	NUM
admet-207	189	26	)	)	PUNCT
admet-207	189	27	e0133174	e0133174	PROPN
admet-207	189	28	.	.	PUNCT
admet-207	190	1	[	[	X
admet-207	190	2	28	28	NUM
admet-207	190	3	]	]	X
admet-207	190	4	e.	e.	PROPN
admet-207	190	5	hiyama	hiyama	PROPN
admet-207	190	6	,	,	PUNCT
admet-207	190	7	k.	k.	PROPN
admet-207	190	8	hiyama	hiyama	PROPN
admet-207	190	9	,	,	PUNCT
admet-207	190	10	t.	t.	PROPN
admet-207	190	11	yokoyama	yokoyama	PROPN
admet-207	190	12	,	,	PUNCT
admet-207	190	13	y.	y.	PROPN
admet-207	190	14	matsuura	matsuura	PROPN
admet-207	190	15	,	,	PUNCT
admet-207	190	16	m.a	m.a	PROPN
admet-207	190	17	.	.	PROPN
admet-207	190	18	piatyszek	piatyszek	PROPN
admet-207	190	19	,	,	PUNCT
admet-207	190	20	j.w	j.w	PROPN
admet-207	190	21	.	.	PROPN
admet-207	190	22	shay	shay	PROPN
admet-207	190	23	,	,	PUNCT
admet-207	190	24	nat	nat	PROPN
admet-207	190	25	.	.	PUNCT
admet-207	191	1	med	med	PROPN
admet-207	191	2	.	.	PROPN
admet-207	191	3	1	1	NUM
admet-207	191	4	(	(	PUNCT
admet-207	191	5	1995	1995	NUM
admet-207	191	6	)	)	PUNCT
admet-207	191	7	249255	249255	NUM
admet-207	191	8	.	.	PUNCT
admet-207	192	1	[	[	X
admet-207	192	2	29	29	NUM
admet-207	192	3	]	]	X
admet-207	192	4	e.	e.	PROPN
admet-207	192	5	hiyama	hiyama	PROPN
admet-207	192	6	,	,	PUNCT
admet-207	192	7	t.	t.	PROPN
admet-207	192	8	yokoyama	yokoyama	PROPN
admet-207	192	9	,	,	PUNCT
admet-207	192	10	n.	n.	PROPN
admet-207	192	11	tatsumoto	tatsumoto	PROPN
admet-207	192	12	,	,	PUNCT
admet-207	192	13	k.	k.	PROPN
admet-207	192	14	hiyama	hiyama	PROPN
admet-207	192	15	,	,	PUNCT
admet-207	192	16	y.	y.	PROPN
admet-207	192	17	imamura	imamura	PROPN
admet-207	192	18	,	,	PUNCT
admet-207	192	19	y.	y.	PROPN
admet-207	192	20	murakami	murakami	NOUN
admet-207	192	21	,	,	PUNCT
admet-207	192	22	t.	t.	PROPN
admet-207	192	23	kodama	kodama	PROPN
admet-207	192	24	,	,	PUNCT
admet-207	192	25	m.a	m.a	PROPN
admet-207	192	26	.	.	PROPN
admet-207	192	27	piatyszek	piatyszek	PROPN
admet-207	192	28	,	,	PUNCT
admet-207	192	29	j.w	j.w	PROPN
admet-207	192	30	.	.	PROPN
admet-207	192	31	shay	shay	PROPN
admet-207	192	32	,	,	PUNCT
admet-207	192	33	y.	y.	PROPN
admet-207	192	34	matsuura	matsuura	PROPN
admet-207	192	35	,	,	PUNCT
admet-207	192	36	cancer	cancer	NOUN
admet-207	192	37	res	re	NOUN
admet-207	192	38	.	.	PUNCT
admet-207	193	1	55	55	NUM
admet-207	193	2	(	(	PUNCT
admet-207	193	3	1995	1995	NUM
admet-207	193	4	)	)	PUNCT
admet-207	193	5	3258	3258	NUM
admet-207	193	6	-	-	SYM
admet-207	193	7	3262	3262	NUM
admet-207	193	8	.	.	PUNCT
admet-207	194	1	[	[	X
admet-207	194	2	30	30	NUM
admet-207	194	3	]	]	X
admet-207	194	4	e.	e.	PROPN
admet-207	194	5	hiyama	hiyama	PROPN
admet-207	194	6	,	,	PUNCT
admet-207	194	7	t.	t.	PROPN
admet-207	194	8	kodama	kodama	PROPN
admet-207	194	9	,	,	PUNCT
admet-207	194	10	k.	k.	PROPN
admet-207	194	11	shinbara	shinbara	PROPN
admet-207	194	12	,	,	PUNCT
admet-207	194	13	t.	t.	PROPN
admet-207	194	14	iwao	iwao	PROPN
admet-207	194	15	,	,	PUNCT
admet-207	194	16	m.	m.	NOUN
admet-207	194	17	itoh	itoh	PROPN
admet-207	194	18	,	,	PUNCT
admet-207	194	19	k.	k.	PROPN
admet-207	194	20	hiyama	hiyama	PROPN
admet-207	194	21	,	,	PUNCT
admet-207	194	22	j.w	j.w	PROPN
admet-207	194	23	.	.	PROPN
admet-207	194	24	shay	shay	PROPN
admet-207	194	25	,	,	PUNCT
admet-207	194	26	y.	y.	PROPN
admet-207	194	27	matsuura	matsuura	PROPN
admet-207	194	28	,	,	PUNCT
admet-207	194	29	t.	t.	PROPN
admet-207	194	30	yokoyama	yokoyama	PROPN
admet-207	194	31	,	,	PUNCT
admet-207	194	32	cancer	cancer	NOUN
admet-207	194	33	res	re	NOUN
admet-207	194	34	57	57	NUM
admet-207	194	35	(	(	PUNCT
admet-207	194	36	1997	1997	NUM
admet-207	194	37	)	)	PUNCT
admet-207	194	38	326	326	NUM
admet-207	194	39	-	-	SYM
admet-207	194	40	331	331	NUM
admet-207	194	41	.	.	PUNCT
admet-207	195	1	admet	admet	PROPN
admet-207	195	2	&	&	CCONJ
admet-207	195	3	dmpk	dmpk	PROPN
admet-207	195	4	3(3	3(3	NUM
admet-207	195	5	)	)	PUNCT
admet-207	195	6	(	(	PUNCT
admet-207	195	7	2015	2015	NUM
admet-207	195	8	)	)	PUNCT
admet-207	195	9	254	254	NUM
admet-207	195	10	-	-	SYM
admet-207	195	11	259	259	NUM
admet-207	195	12	telomere	telomere	NOUN
admet-207	195	13	and	and	CCONJ
admet-207	195	14	telomerase	telomerase	NOUN
admet-207	195	15	in	in	ADP
admet-207	195	16	degenerative	degenerative	ADJ
admet-207	195	17	diseases	disease	NOUN
admet-207	195	18	doi	doi	NOUN
admet-207	195	19	:	:	PUNCT
admet-207	195	20	10.5599	10.5599	NUM
admet-207	195	21	/	/	SYM
admet-207	195	22	admet.3.3.207	admet.3.3.207	PROPN
admet-207	195	23	259	259	NUM
admet-207	195	24	[	[	X
admet-207	195	25	31	31	NUM
admet-207	195	26	]	]	PUNCT
admet-207	195	27	e.	e.	PROPN
admet-207	195	28	hiyama	hiyama	PROPN
admet-207	195	29	,	,	PUNCT
admet-207	195	30	k.	k.	PROPN
admet-207	195	31	hiyama	hiyama	PROPN
admet-207	195	32	,	,	PUNCT
admet-207	195	33	oncogene	oncogene	NOUN
admet-207	195	34	21	21	NUM
admet-207	195	35	(	(	PUNCT
admet-207	195	36	2002	2002	NUM
admet-207	195	37	)	)	PUNCT
admet-207	195	38	643	643	NUM
admet-207	195	39	-	-	SYM
admet-207	195	40	649	649	NUM
admet-207	195	41	.	.	PUNCT
admet-207	196	1	[	[	X
admet-207	196	2	32	32	NUM
admet-207	196	3	]	]	X
admet-207	196	4	j.w	j.w	PROPN
admet-207	196	5	.	.	PROPN
admet-207	196	6	shay	shay	PROPN
admet-207	196	7	,	,	PUNCT
admet-207	196	8	cancer	cancer	PROPN
admet-207	196	9	j.	j.	PROPN
admet-207	196	10	sci	sci	PROPN
admet-207	196	11	.	.	PROPN
admet-207	196	12	am	be	AUX
admet-207	196	13	.	.	PROPN
admet-207	197	1	4	4	NUM
admet-207	197	2	(	(	PUNCT
admet-207	197	3	1998	1998	NUM
admet-207	197	4	)	)	PUNCT
admet-207	197	5	26	26	NUM
admet-207	197	6	-	-	SYM
admet-207	197	7	34	34	NUM
admet-207	197	8	.	.	PUNCT
admet-207	198	1	[	[	X
admet-207	198	2	33	33	NUM
admet-207	198	3	]	]	X
admet-207	198	4	n.w	n.w	PROPN
admet-207	198	5	.	.	PROPN
admet-207	198	6	kim	kim	PROPN
admet-207	198	7	,	,	PUNCT
admet-207	198	8	m.a	m.a	PROPN
admet-207	198	9	.	.	PROPN
admet-207	198	10	piatyszek	piatyszek	PROPN
admet-207	198	11	,	,	PUNCT
admet-207	198	12	k.r	k.r	PROPN
admet-207	198	13	.	.	PROPN
admet-207	198	14	prowse	prowse	PROPN
admet-207	198	15	,	,	PUNCT
admet-207	198	16	c.b	c.b	PROPN
admet-207	198	17	.	.	PROPN
admet-207	198	18	harley	harley	PROPN
admet-207	198	19	,	,	PUNCT
admet-207	198	20	m.d	m.d	PROPN
admet-207	198	21	.	.	PROPN
admet-207	198	22	west	west	PROPN
admet-207	198	23	,	,	PUNCT
admet-207	198	24	p.l	p.l	PROPN
admet-207	198	25	.	.	PROPN
admet-207	198	26	ho	ho	PROPN
admet-207	198	27	,	,	PUNCT
admet-207	198	28	g.m	g.m	PROPN
admet-207	198	29	.	.	PROPN
admet-207	198	30	coviello	coviello	PROPN
admet-207	198	31	,	,	PUNCT
admet-207	198	32	wright	wright	PROPN
admet-207	198	33	we	we	PRON
admet-207	198	34	,	,	PUNCT
admet-207	198	35	weinrich	weinrich	PRON
admet-207	198	36	sl	sl	PROPN
admet-207	198	37	,	,	PUNCT
admet-207	198	38	shay	shay	PROPN
admet-207	198	39	jw	jw	PROPN
admet-207	198	40	.	.	PROPN
admet-207	198	41	science	science	PROPN
admet-207	198	42	,	,	PUNCT
admet-207	198	43	266	266	NUM
admet-207	198	44	(	(	PUNCT
admet-207	198	45	1994	1994	NUM
admet-207	198	46	)	)	PUNCT
admet-207	198	47	2011	2011	NUM
admet-207	198	48	-	-	SYM
admet-207	198	49	2015	2015	NUM
admet-207	198	50	.	.	PUNCT
admet-207	199	1	[	[	X
admet-207	199	2	34	34	NUM
admet-207	199	3	]	]	X
admet-207	199	4	c.	c.	PROPN
admet-207	199	5	chadeneau	chadeneau	PROPN
admet-207	199	6	,	,	PUNCT
admet-207	199	7	k.	k.	PROPN
admet-207	199	8	hay	hay	PROPN
admet-207	199	9	,	,	PUNCT
admet-207	199	10	h.w	h.w	PROPN
admet-207	199	11	.	.	PROPN
admet-207	199	12	hirte	hirte	PROPN
admet-207	199	13	,	,	PUNCT
admet-207	199	14	s.	s.	PROPN
admet-207	199	15	gallinger	gallinger	PROPN
admet-207	199	16	,	,	PUNCT
admet-207	199	17	s.	s.	PROPN
admet-207	199	18	bacchetti	bacchetti	PROPN
admet-207	199	19	,	,	PUNCT
admet-207	199	20	cancer	cancer	NOUN
admet-207	199	21	res	re	NOUN
admet-207	199	22	.	.	PUNCT
admet-207	200	1	55	55	NUM
admet-207	200	2	(	(	PUNCT
admet-207	200	3	1995	1995	NUM
admet-207	200	4	)	)	PUNCT
admet-207	200	5	2533	2533	NUM
admet-207	200	6	-	-	SYM
admet-207	200	7	2536	2536	NUM
admet-207	200	8	.	.	PUNCT
admet-207	201	1	[	[	X
admet-207	201	2	35	35	NUM
admet-207	201	3	]	]	X
admet-207	201	4	h.	h.	NOUN
admet-207	201	5	tahara	tahara	PROPN
admet-207	201	6	,	,	PUNCT
admet-207	201	7	t.	t.	PROPN
admet-207	201	8	nakanishi	nakanishi	PROPN
admet-207	201	9	,	,	PUNCT
admet-207	201	10	m.	m.	NOUN
admet-207	201	11	kitamoto	kitamoto	PROPN
admet-207	201	12	,	,	PUNCT
admet-207	201	13	r.	r.	PROPN
admet-207	201	14	nakashio	nakashio	PROPN
admet-207	201	15	,	,	PUNCT
admet-207	201	16	j.w	j.w	PROPN
admet-207	201	17	.	.	PROPN
admet-207	201	18	shay	shay	PROPN
admet-207	201	19	,	,	PUNCT
admet-207	201	20	e.	e.	PROPN
admet-207	201	21	tahara	tahara	PROPN
admet-207	201	22	,	,	PUNCT
admet-207	201	23	g.	g.	PROPN
admet-207	201	24	kajiyama	kajiyama	PROPN
admet-207	201	25	,	,	PUNCT
admet-207	201	26	t.	t.	PROPN
admet-207	201	27	ide	ide	NOUN
admet-207	201	28	,	,	PUNCT
admet-207	201	29	cancer	cancer	NOUN
admet-207	201	30	res	re	NOUN
admet-207	201	31	.	.	PUNCT
admet-207	201	32	55	55	NUM
admet-207	201	33	(	(	PUNCT
admet-207	201	34	1995	1995	NUM
admet-207	201	35	)	)	PUNCT
admet-207	201	36	2734	2734	NUM
admet-207	201	37	-	-	SYM
admet-207	201	38	2736	2736	NUM
admet-207	201	39	.	.	PUNCT
admet-207	202	1	[	[	X
admet-207	202	2	36	36	NUM
admet-207	202	3	]	]	X
admet-207	202	4	h.	h.	PROPN
admet-207	202	5	kojima	kojima	PROPN
admet-207	202	6	,	,	PUNCT
admet-207	202	7	o.	o.	PROPN
admet-207	202	8	yokosuka	yokosuka	PROPN
admet-207	202	9	,	,	PUNCT
admet-207	202	10	f.	f.	PROPN
admet-207	202	11	imazeki	imazeki	PROPN
admet-207	202	12	,	,	PUNCT
admet-207	202	13	h.	h.	PROPN
admet-207	202	14	saisho	saisho	PROPN
admet-207	202	15	,	,	PUNCT
admet-207	202	16	m.	m.	NOUN
admet-207	202	17	omata	omata	PROPN
admet-207	202	18	,	,	PUNCT
admet-207	202	19	gastroenterology	gastroenterology	NOUN
admet-207	202	20	112	112	NUM
admet-207	202	21	(	(	PUNCT
admet-207	202	22	1997	1997	NUM
admet-207	202	23	)	)	PUNCT
admet-207	202	24	493	493	NUM
admet-207	202	25	-	-	SYM
admet-207	202	26	500	500	NUM
admet-207	202	27	.	.	PUNCT
admet-207	203	1	[	[	X
admet-207	203	2	37	37	NUM
admet-207	203	3	]	]	X
admet-207	203	4	w.e	w.e	PROPN
admet-207	203	5	.	.	PROPN
admet-207	203	6	wright	wright	PROPN
admet-207	203	7	,	,	PUNCT
admet-207	203	8	j.w	j.w	PROPN
admet-207	203	9	.	.	PROPN
admet-207	203	10	shay	shay	PROPN
admet-207	203	11	,	,	PUNCT
admet-207	203	12	m.a	m.a	PROPN
admet-207	203	13	.	.	PROPN
admet-207	203	14	piatyszek	piatyszek	NOUN
admet-207	203	15	,	,	PUNCT
admet-207	203	16	nucleic	nucleic	ADJ
admet-207	203	17	acid	acid	NOUN
admet-207	203	18	res	re	NOUN
admet-207	203	19	.	.	PUNCT
admet-207	204	1	23	23	NUM
admet-207	204	2	(	(	PUNCT
admet-207	204	3	1995	1995	NUM
admet-207	204	4	)	)	PUNCT
admet-207	204	5	3794	3794	NUM
admet-207	204	6	-	-	SYM
admet-207	204	7	3795	3795	NUM
admet-207	204	8	.	.	PUNCT
admet-207	205	1	[	[	X
admet-207	205	2	38	38	NUM
admet-207	205	3	]	]	PUNCT
admet-207	205	4	m.	m.	NOUN
admet-207	205	5	engelhardt	engelhardt	PROPN
admet-207	205	6	,	,	PUNCT
admet-207	205	7	p.	p.	NOUN
admet-207	205	8	drullinsky	drullinsky	NOUN
admet-207	205	9	,	,	PUNCT
admet-207	205	10	j.	j.	PROPN
admet-207	205	11	guillem	guillem	PROPN
admet-207	205	12	,	,	PUNCT
admet-207	205	13	m.a	m.a	PROPN
admet-207	205	14	.	.	PROPN
admet-207	205	15	moore	moore	PROPN
admet-207	205	16	,	,	PUNCT
admet-207	205	17	clin	clin	PROPN
admet-207	205	18	.	.	PUNCT
admet-207	206	1	cancer	cancer	NOUN
admet-207	206	2	res	re	NOUN
admet-207	206	3	.	.	PUNCT
admet-207	207	1	3(11	3(11	NUM
admet-207	207	2	)	)	PUNCT
admet-207	207	3	(	(	PUNCT
admet-207	207	4	1997	1997	NUM
admet-207	207	5	)	)	PUNCT
admet-207	207	6	1931	1931	NUM
admet-207	207	7	-	-	SYM
admet-207	207	8	41	41	NUM
admet-207	207	9	.	.	PUNCT
admet-207	208	1	[	[	X
admet-207	208	2	39	39	NUM
admet-207	208	3	]	]	SYM
admet-207	208	4	a.a	a.a	PROPN
admet-207	208	5	.	.	PROPN
admet-207	208	6	avillion	avillion	PROPN
admet-207	208	7	,	,	PUNCT
admet-207	208	8	m.a	m.a	PROPN
admet-207	208	9	.	.	PROPN
admet-207	208	10	piatyszek	piatyszek	PROPN
admet-207	208	11	,	,	PUNCT
admet-207	208	12	j.	j.	PROPN
admet-207	208	13	gupta	gupta	PROPN
admet-207	208	14	,	,	PUNCT
admet-207	208	15	j.w	j.w	PROPN
admet-207	208	16	.	.	PROPN
admet-207	208	17	shay	shay	PROPN
admet-207	208	18	,	,	PUNCT
admet-207	208	19	s.	s.	PROPN
admet-207	208	20	bacchetti	bacchetti	PROPN
admet-207	208	21	,	,	PUNCT
admet-207	208	22	c.w	c.w	PROPN
admet-207	208	23	.	.	PROPN
admet-207	208	24	greider	greider	NOUN
admet-207	208	25	,	,	PUNCT
admet-207	208	26	cancer	cancer	NOUN
admet-207	208	27	res	re	NOUN
admet-207	208	28	.	.	PUNCT
admet-207	209	1	56	56	NUM
admet-207	209	2	(	(	PUNCT
admet-207	209	3	1996	1996	NUM
admet-207	209	4	)	)	PUNCT
admet-207	209	5	645	645	NUM
admet-207	209	6	-	-	SYM
admet-207	209	7	650	650	NUM
admet-207	209	8	.	.	PUNCT
admet-207	210	1	[	[	X
admet-207	210	2	40	40	NUM
admet-207	210	3	]	]	PUNCT
admet-207	210	4	h.	h.	PROPN
admet-207	210	5	kuniyasu	kuniyasu	PROPN
admet-207	210	6	,	,	PUNCT
admet-207	210	7	t.	t.	PROPN
admet-207	210	8	domen	domen	PROPN
admet-207	210	9	,	,	PUNCT
admet-207	210	10	t.	t.	PROPN
admet-207	210	11	hamamoto	hamamoto	PROPN
admet-207	210	12	,	,	PUNCT
admet-207	210	13	h.	h.	PROPN
admet-207	210	14	yokozaki	yokozaki	PROPN
admet-207	210	15	,	,	PUNCT
admet-207	210	16	w.	w.	PROPN
admet-207	210	17	yasui	yasui	PROPN
admet-207	210	18	,	,	PUNCT
admet-207	210	19	h.	h.	PROPN
admet-207	210	20	tanara	tanara	PROPN
admet-207	210	21	,	,	PUNCT
admet-207	210	22	jpn	jpn	PROPN
admet-207	210	23	.	.	PUNCT
admet-207	211	1	j.	j.	PROPN
admet-207	211	2	cancer	cancer	PROPN
admet-207	211	3	res	re	NOUN
admet-207	211	4	.	.	PUNCT
admet-207	212	1	88	88	NUM
admet-207	212	2	(	(	PUNCT
admet-207	212	3	1997	1997	NUM
admet-207	212	4	)	)	PUNCT
admet-207	212	5	103	103	NUM
admet-207	212	6	-	-	SYM
admet-207	212	7	107	107	NUM
admet-207	212	8	.	.	PUNCT
admet-207	213	1	[	[	X
admet-207	213	2	41	41	NUM
admet-207	213	3	]	]	X
admet-207	213	4	t.a	t.a	PROPN
admet-207	213	5	.	.	PROPN
admet-207	213	6	augustine	augustine	PROPN
admet-207	213	7	,	,	PUNCT
admet-207	213	8	m.	m.	PROPN
admet-207	213	9	baig	baig	PROPN
admet-207	213	10	,	,	PUNCT
admet-207	213	11	a.	a.	NOUN
admet-207	213	12	sood	sood	PROPN
admet-207	213	13	,	,	PUNCT
admet-207	213	14	t.	t.	PROPN
admet-207	213	15	budagov	budagov	NOUN
admet-207	213	16	,	,	PUNCT
admet-207	213	17	g.	g.	PROPN
admet-207	213	18	atzmon	atzmon	PROPN
admet-207	213	19	,	,	PUNCT
admet-207	213	20	j.m	j.m	PROPN
admet-207	213	21	.	.	PROPN
admet-207	213	22	mariadason	mariadason	PROPN
admet-207	213	23	,	,	PUNCT
admet-207	213	24	s.	s.	PROPN
admet-207	213	25	aparo	aparo	PROPN
admet-207	213	26	,	,	PUNCT
admet-207	213	27	r.	r.	PROPN
admet-207	213	28	maitra	maitra	PROPN
admet-207	213	29	,	,	PUNCT
admet-207	213	30	s.	s.	PROPN
admet-207	213	31	goel	goel	PROPN
admet-207	213	32	,	,	PUNCT
admet-207	213	33	br	br	PROPN
admet-207	213	34	.	.	PUNCT
admet-207	214	1	j.	j.	PROPN
admet-207	214	2	cancer	cancer	PROPN
admet-207	214	3	112(2	112(2	NUM
admet-207	214	4	)	)	PUNCT
admet-207	214	5	(	(	PUNCT
admet-207	214	6	2015	2015	NUM
admet-207	214	7	)	)	PUNCT
admet-207	214	8	313	313	NUM
admet-207	214	9	-	-	SYM
admet-207	214	10	318	318	NUM
admet-207	214	11	.	.	PUNCT
admet-207	215	1	[	[	X
admet-207	215	2	42	42	NUM
admet-207	215	3	]	]	X
admet-207	215	4	n.	n.	NOUN
admet-207	215	5	tatsumoto	tatsumoto	PROPN
admet-207	215	6	,	,	PUNCT
admet-207	215	7	e.	e.	PROPN
admet-207	215	8	hiyama	hiyama	PROPN
admet-207	215	9	,	,	PUNCT
admet-207	215	10	y.	y.	PROPN
admet-207	215	11	murakami	murakami	PROPN
admet-207	215	12	,	,	PUNCT
admet-207	215	13	y.	y.	PROPN
admet-207	215	14	imamura	imamura	PROPN
admet-207	215	15	,	,	PUNCT
admet-207	215	16	j.w	j.w	PROPN
admet-207	215	17	.	.	PROPN
admet-207	215	18	shay	shay	PROPN
admet-207	215	19	,	,	PUNCT
admet-207	215	20	y.	y.	PROPN
admet-207	215	21	matsuura	matsuura	PROPN
admet-207	215	22	,	,	PUNCT
admet-207	215	23	t.	t.	PROPN
admet-207	215	24	yokoyama	yokoyama	PROPN
admet-207	215	25	,	,	PUNCT
admet-207	215	26	clin	clin	PROPN
admet-207	215	27	.	.	PUNCT
admet-207	216	1	cancer	cancer	NOUN
admet-207	216	2	res	re	NOUN
admet-207	216	3	.	.	PUNCT
admet-207	216	4	6(7	6(7	NUM
admet-207	216	5	)	)	PUNCT
admet-207	216	6	(	(	PUNCT
admet-207	216	7	2000	2000	NUM
admet-207	216	8	)	)	PUNCT
admet-207	216	9	2696	2696	NUM
admet-207	216	10	-	-	SYM
admet-207	216	11	701	701	NUM
admet-207	216	12	.	.	PUNCT
admet-207	217	1	©	©	PROPN
admet-207	217	2	2015	2015	NUM
admet-207	217	3	by	by	ADP
admet-207	217	4	the	the	DET
admet-207	217	5	authors	author	NOUN
admet-207	217	6	;	;	PUNCT
admet-207	217	7	licensee	licensee	PROPN
admet-207	217	8	iapc	iapc	PROPN
admet-207	217	9	,	,	PUNCT
admet-207	217	10	zagreb	zagreb	PROPN
admet-207	217	11	,	,	PUNCT
admet-207	217	12	croatia	croatia	PROPN
admet-207	217	13	.	.	PUNCT
admet-207	218	1	this	this	DET
admet-207	218	2	article	article	NOUN
admet-207	218	3	is	be	AUX
admet-207	218	4	an	an	DET
admet-207	218	5	open	open	ADJ
admet-207	218	6	-	-	PUNCT
admet-207	218	7	access	access	NOUN
admet-207	218	8	article	article	NOUN
admet-207	218	9	distributed	distribute	VERB
admet-207	218	10	under	under	ADP
admet-207	218	11	the	the	DET
admet-207	218	12	terms	term	NOUN
admet-207	218	13	and	and	CCONJ
admet-207	218	14	conditions	condition	NOUN
admet-207	218	15	of	of	ADP
admet-207	218	16	the	the	DET
admet-207	218	17	creative	creative	ADJ
admet-207	218	18	commons	common	NOUN
admet-207	218	19	attribution	attribution	NOUN
admet-207	218	20	license(http://creativecommons.org	license(http://creativecommons.org	X
admet-207	218	21	/	/	SYM
admet-207	218	22	licenses	license	NOUN
admet-207	218	23	/	/	SYM
admet-207	218	24	by/3.0/	by/3.0/	NOUN
admet-207	218	25	)	)	PUNCT
admet-207	218	26	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN